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2 Introduction 
 
Abstract 
Tissue loss or end-stage organ failure caused by injury or other types of damage 
is one of the most devastating and costly problems in human health care.  
 
Although surgical strategies have been developed to deal with these problems, 
and significant advances have been achieved in organ transplantation, it is 
extremely limited by a critical donor shortage and the necessity of lifelong 
immunosuppression and its serious complications. In the USA, more than 6,000 
people die each year as a result of shortage of donor organs.  
 
Tissue engineering [TE] is seen by many as the only way to address this 
shortage. TE is an interdisciplinary field that draws from materials science, cell 
biology, biotechnology and chemistry, and strives to offer a new solution to tissue 
loss or organ failure through the use of synthetic, hybrid, or natural materials that 
have been designed and fabricated into a 3-dimensional scaffolds that provide 
support and allow cell attachment, proliferation, differentiation and function. 
 
However, Skin and cartilage are the only two tissues grown under laboratory 
conditions that have achieved successful clinical application. The main reason for 
this is that cartilage doesn’t require blood vessels or nerves and skin is sustained 
by nutrients that diffuse through the thickness of the cells that make up the graft. 
Attempts to grow more biologically challenging tissue and organs have been had 
mixed results. The obstacles and challenges that have to be overcome include: 
1. Graft loss/failure due to at the cyto-incompatibility at the graft-biomaterial 
interface and bio-incompatibility host-biomaterial interface.  
2. Inadequate neovascularization and nutrient channels to support cell 
survival deep in the interior of the scaffolds. 
3. Immuno-rejection of allogenic graft. 
4. Lack of healthy easily accessible cells for use in tissue engineering 
 
To this end we have developed “smart” biomaterials with nano-scale architecture 
to elicit desirable cell response (cytocompatibility) at the cell-biomaterial interface 
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and desirable host response (biocompatibility) at the host biomaterial interface. 
We then designed and microfabricated an original scaffold that incorporated the 
“smart” architecture and microfluidic network to permit the flow of nutrient-rich 
media deep in the interior. The scaffold consists of two microporous hemi-
membranes that are superimposed and aligned in such a way that the 
micropores are laterally offset. Sandwiched between these hemi-membranes is a 
microfluidic channel network that runs perpendicular to the micropore axis and 
permits interconnectivity between the laterally offset micropores. 
By decreasing the size of the channels from the micro- to the nano- scale the 
scaffold acquires a another “smart” characteristic as a immuno-isolating 
membrane. 
 
To examine the scaffold’s potential for tissue regeneration, muscle myoblast cells 
(mouse C2C12 cell-line), neuroblastomas (mouse PC12 cell-line) and embryonic 
stem cells (mouse TBV-2 cell-line) were seeded and cultured on the scaffolds. 
Biocompatibility was evaluated by subcutaneous implantation of the scaffold in 
mice. Results show that myoblast and neuroblastomas attached, proliferated and 
differentiated. The exponential cell proliferation associated with in vitro embryonic 
stem cell culture was controlled. In vivo studies demonstrated scaffold-host 
integration as evidenced by vascular colonisation of the scaffold.. 
 
By developing the ability to construct and control the following scaffold 
parameters; microporous architecture; microfluidic interconnectivity and canal 
size; the external and internal shape of the scaffold and it’s multi-scaled surface 
architectures, the “smart” scaffold developed in our laboratories have great 
potential as an ideal scaffold for tissue engineering 
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ABSTRACT (Italiano) 
 
Nella cura del benessere degli uomini, tra i problemi di maggior impatto e costo 
si trovano la perdita di tessuti e di funzionalità degli organi, causati da ferite o 
incidenti di altro genere. 
Sebbene siano state sviluppate efficaci strategie chirurgiche per ovviare a tali 
problemi, e nonostante i significativi avanzamenti tecnici raggiunti nel campo del 
trapianto degli organi, il ricorso a tale soluzione è fortemente limitato dal basso 
numero di donatori di organi e dalla necessità di durature terapie immuno-
soppressive, con il loro portato di serie complicazioni. Basti pensare che a causa 
della mancanza di un adeguato numero di donatori, solo negli USA ogni anno 
muoiono più di 6000 persone. 
Secondo il parere di molti, la strada più promettente per affrontare questo 
problema è la Ingegneria dei Tessuti Biologici (ovvero Tissue Engineering [TE], 
dall’acronimo dell’equivalente inglese). Si tratta di un approccio interdisciplinare, 
che combinando conoscenze e tecnologie dai campi della Scienza dei Materiali, 
Biologia Cellulare, Biotecnologia e Chimica offre la possibilità, in principio, di 
trovare soluzioni innovative per la sostituzione di tessuti o organi non più 
funzionali; la strada maestra in questo campo è la progettazione e costruzione di 
strutture tri-dimensionali (scaffold) capaci di provvedere al supporto funzionale di 
cellule cresciute in vitro, integrando materiali sintetici, naturali e ibridi. 
Tuttavia, al momento soltanto pelle e cartilagini sono state cresciute in 
condizioni controllate da laboratorio e hanno raggiunto lo stadio della 
applicazione clinica. Il motivo fondamentale per tale successo, e per la 
limitazione a questi due soli casi, è che la cartilagine non necessita di 
vascolarizzazione o innervazione per sostentarsi, e la pelle ottiene i suoi nutrienti 
per mezzo della diffusione attraverso gli strati di cellule che la sostengono e ne 
garantiscono l’attecchimento. 
Tentativi per crescere altri tipi di tessuti e organi hanno incontrato gravi 
difficoltà; 
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1. perdita di adesione a causa della cito-incompatibilità all’interfaccia di 
connessione e della bio-incompatibilità tra i materiali dell’impianto e 
il corpo ospitante 
2. scarsa o inadeguata vascolarizzazione dell’impianto, tale per cui le 
cellule all’interno della struttura 3-D non vengono raggiunte dai 
nutrienti necessari per una sopravvivenza a lungo termine 
3. rigetto immunologico del tessuto trapianto 
4. mancanza di facile accesso alle cellule necessarie per la 
costruzione degli impianti 
 
Con lo scopo di rispondere a queste richieste, abbiamo sviluppato bio-materiali 
“smart” contraddistinti da una architettura a livello nano-metrico, capaci di 
stimolare la desiderata risposta cellulare (compatibilità citologica) all’interfaccia 
con il bio-materiale stesso, e capace di promuovere la bio-compatibilità con il 
corpo ospitante. Usando le tecniche della micro-fabbricazione, abbiamo quindi 
progettato e realizzato una struttura 3-D originale (lo scaffold) che incorpora tale 
architettura “smart” e il sistema micro-fluidico che garantisce l’apporto del flusso 
dei nutrienti al suo interno. Tale struttura consiste da membrane sovrapposte ed 
allineate in modo che lateralmente si aprano dei pori di comunicazione con 
dimensioni micrometriche. Compreso tra queste membrane si trova il sistema 
microfluidico, capace di garantire l’interconnessione trai pori con un sistema di 
canali che scorre perpendicolarmente all’asse dei pori stessi. 
Una ulteriore caratteristica di questo sistema è che riducendo la scala dei 
canali microfluidici al livello di scala nano-metrica, lo “scaffold” acquisisce 
proprietà immuno-isolanti. 
Per lo studio della sue potenzialità nel campo della rigenerazione tissutale, 
abbiamo cresciuto nello “scaffold” mioblasti muscolari (linea cellulare C2C12 del 
topo), neuroblastomi (linea cellulare PC12 del topo) e cellule staminali embrionali 
(TBV-2 del topo). La biocompatibilità è stata valutata impiantando lo “scaffold” in 
topi da laboratorio. I risultati mostrano come i mioblastomi e i neuroblastomi 
aderiscono allo “scaffold”, proliferano e si differenziano. Abbiamo controllato la 
proliferazione esponenziale associata con la cultura in vitro delle cellule staminali 
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embrionali e lo studio delle condizioni in vivo dimostra la integrazione dello 
“scaffold” nel corpo dell’ospite, come risultato della riuscita vascolarizzazione 
della sua struttura. 
Con il controllo della architettura micro-porosa; interconnettività microfluidica e 
dimensione dei canali; della geometria esterna ed interna e della sua struttura e 
conformazione superficiale a scala nano-metrica, lo “scaffold” risultante, 
sviluppato nei nostri laboratori, mostra enormi potenzialità come struttura ideale 
per la Ingegneria dei Tessuti Biologici. 
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Tissue loss or end-stage organ failure caused by injury or other types of damage 
is one of the most devastating and costly problems in human health care. 
Surgical strategies that have been developed to deal with these problems include 
organ transplantation from one individual to another, tissue transfer from a 
healthy site to the diseased site in the same individual, and replacement by using 
mechanical devices such as joint prosthesis or dialysis machine 
Though significant advances have been achieved in terms of health care by 
these therapeutic options, many limitations and unsolved issues remain. Organ 
transplantation is extremely limited by a critical donor shortage [1] and the 
necessity of lifelong immunosuppression and its serious complications. In the 
USA, more than 6,000 people die each year as a result of shortage of donor 
organs. In 1990, the difference between the number of organs donated and the 
number of patients waiting for organs was 9,000 [2]. Today the waiting list of 
transplant candidates is 94,871 [1]. 
Tissue engineering [TE] is seen by many as the only way to address this 
shortage. TE is an interdisciplinary field that draws from materials science, cell 
biology, biotechnology and chemistry, and strives to offer a new solution to tissue 
loss or organ failure through the use of synthetic, hybrid, or natural materials that 
have been designed or fabricated into a 3-dimensional structure (scaffolds). 
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Artificially engineered scaffolds are a key requirement in TE. The fundamental 
requirements of these scaffolds are that they: provide mechanical support, are 
biocompatible, degrade over a predetermined period of time, can be moulded 
into the desired shape, are easy to sterilize and allow cell attachment 
proliferation, differentiation and function. 
Biomedical scaffolds have been used since ancient times - for example, ancient 
Incas successfully used gold (Au) plates to repair cranial defects [3]. Until the last 
few decades of the 20th century, the criteria used in choosing materials for 
scaffolds has fundamentally changed very little and usually scaffolds were 
chosen that were functional because of their inertness. Since the discovery in the 
1960s that some glass ceramics actively bond to living bone, the focus has 
shifted away from inert materials and towards materials that are bioactive – those 
that deliberately elicit a specific response from the body. Currently, most 
scaffolds provide a three dimensional environment in which tissue can grow and 
develop, so that it is able to reproduce the functions of the tissue it is intended to 
replace 
To date, many tissues have been developed in the laboratory, and laboratory-
grown tissues are readily available on market shelves. For example, Laboratory 
expanded skin cells are provided by CellTran Ltd (UK) for wound healing in 
patients with extensive burns and chronic wounds. Cartilage is another tissue that 
is grown routinely by Mercy Tissue Engineering (Australia) to provide cartilage for 
knee implants. However, Skin and cartilage are the only two tissues grown under 
laboratory conditions that have achieved successful clinical application. The main 
reason for this is that cartilage doesn’t require blood vessels or nerves and skin is 
sustained by nutrients that diffuse through the thickness of the cells that make up 
the graft. 
Attempts have been made to grow more biologically challenging tissue and 
organs. Up to now, investigators have attempted to grow bone [4], liver [5, 6], 
arteries [7], bladder [8], pancreas [9], nerves [10], heart valves [7], corneas [11], 
and various soft tissues [12] but with disappointing clinical results. 
 
Many obstacles and challenges remain. The fundamental problems involved are 
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5. Graft loss/failure due to bio-incompatibility at the graft-biomaterial and 
host-biomaterial interface.  
6. Inadequate neovascularization of living tissue in the 3-dimensional 
structure. Leading to graft loss. 
7. Immuno-rejection of allogenic graft. 
8. Lack of easily accessible cells for use in tissue engineering. 
Fig 1.1 demonstrates a graphic representation of failure points the in current TE 
assembly chain. 
 
 
Fig. 1.1 Current obstacles and challenges in the Tissue Engineering production chain 
 
It is apparently evident that there is no one-stop-solution. A successful product of 
tissue engineering or organ fabrication will only possible when an adequate 
source of healthy, expandable cells, cell-friendly and host–friendly scaffolds, 
vascular and nervous reconnection and immuno-protection are achieved. 
The mission of this PhD research program was to formulate a comprehensive 
strategy to optimise graft survival and function through all-embracing solutions to 
the identified problems in the tissue engineering production chain so as to 
achieve clinical-grade tissue engineered implants. 
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As a starting point, we looked at nature’s solutions to tissue building and function; 
in particular cellular microenvironment. The cell’s microenvironment is an 
architectural masterpiece with precise structural organisation at macro- micro- 
and nano-scales. We believe that complex cellular processes like proliferation, 
differentiation, organisation and function are precisely controlled and guided by 
this hierarchal 3D architecture. Therefore it can be deduced that full tissue 
viability and function cannot be artificially recovered without rebuilding the 
ultrastructures of the tissue itself. 
 
We report the development of silicon and gold substrates with novel structured 
surface formulations at two scale lengths i.e., at the tens to hundreds of microns 
lengths as supporting scaffolds and at the submicron scale for surface properties, 
that were able to elicit controlled cell proliferation, differentiation and function. 
This cytocompatibility was tested and validated by in vitro cell culture studies 
using muscle myoblast cells (mouse C2C12 cell-line), neuroblastomas (mouse 
PC12 cell-line) and  embryonic stem cells (mouse TBV-2 cell-line). 
 
We further report the development a scaffold with an original design that 
incorporated these smart nanostructured features. In vivo studies demonstrated 
optimal biocompatibility evidenced by marked neovascularisation at the scaffold-
host interface. This was further optimized by coating the scaffold with an 
angiogenic stimulating gel matrix at implantation. 
 
Structural Organization of Research Project. 
The research program was carried out following a Master protocol for the 
development of medical devices. The research work was carried out at the 
following institutions; National Laboratory of Advance Technology and 
NanoScience (TASC) Trieste, Consortium of Moleculare BioMedicine (CMB) 
Trieste, Department of Comparative Anatomy and Cell Biology, University of 
Pavia, and Department of Human Anatomy, faculty of Medicine, University of 
Pavia. Fig 2.2 shows a graphic presentation of the Master Protocol highlighting 
the multi-disciplinary input and the path followed. 
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Fig 1.2 Graphic representation of Master Protocol highlighting the disciplines involved and the 
research path being undertaken. 
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2 
2. Scientific Background  
Designing highly functional scaffolds for tissue engineering requires a fundamental 
understanding of cell/tissue biology and biomaterials science. This chapter provides 
basic working knowledge on concepts in these disciplines. The structural processes that 
control cell viability and tissue function are highlighted and tissue-biomaterial 
interactions are reviewed. 
2.1. Cell and Tissue Biology 
2.1.1. Extracellular Matrix (ECM) 
It is well know that specific biological and chemical composition of tissues is 
critical for tissue function. However, the structural organization is just as 
important, if not more so, as this unique frame defines the three-dimensional 
shape of the tissue at multiple length scales. Typically, this frame consists of a 
complex network of structural and bioactive macromolecules such as proteins, 
proteoglycans, and glycosaminoglycans known in general as the extracellular 
matrix (ECM). The ECM has multiple functions but, in general include: 
1. Mechanical support for cell anchorage 
2. Determination of cell orientation; 
3. Control of cell growth; 
4. Maintenance of cell differentiation; 
5. Scaffolding for orderly tissue renewal; 
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6. Establishment of tissue microenvironment; 
7. Sequestration, storage and presentation of soluble regulatory molecules. 
Matrix components markedly influence the maintenance of cellular phenotypes, 
affecting cell shape, polarity, and differentiated function through receptors for 
specific extracellular matrix molecules on cell surfaces. Cells communicate with 
various matrix components using surface-receptors and peripheral and integral 
membrane proteins; the resultant changes in cytoskeletal organisation and 
possibly in production of other second messengers can modify gene expression. 
Conversely, cells produce and secrete matrix molecules, often vectorially. These 
functions are accomplished by reciprocal instructions between cells and matrix, 
an interaction termed “dynamic reciprocity”. 
Extracellular matrices are generally specialized for particular function, such as 
strength (tendon), filtration (kidney glomerulus), or adhesion (basement 
membrane generally). The extracellular matrix consists of large molecules linked 
together into insoluble composite. The extra cellular matrix is composed of (1) 
fibres (collagen and elastin) and (2) a largely amorphous interfibrillary matrix 
(mainly proteoglycans, noncollagenous glycoproteins, solutes, and water). There 
are two types of matrices: the interstitial matrix and the basal lamina. The major 
component of each is collagen, a cell-binding adhesive glycoprotein, and 
proteoglycans. The interstitial matrix is produced by mesenchymal cells and 
contains fibrillar collagens, fibronectin, hyaluronic acid, and fibril-associated 
proteoglycans. The basal lamina is produced by overlying parenchymal cells. 
Basal laminae contain a meshlike collagen framework, laminin and a large 
heparan sulfate proteoglycan. To produce additional mechanical strength, the 
extracellular matrix becomes calcified during the formation of bones and teeth. 
Although matrix turnover is quite slow in normal mature tissues; type-specific 
extracellular matrix components are turned over and remodelled in response to 
appropriate stimuli, such as tissue damage and repair. 
The fibrillar components of the extracellular matrix include collagen and elastin 
fibres. Collagen represents a family of closely related genetically, biochemically, 
and functionally distinct glycoproteins, of which at least fifteen different types 
have been identified. Fibrillar collagen, also called interstitial collagens, (types I, 
 13
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II, III and V), have periodic cross-striations. Type I, the most abundant, is present 
in most connective tissue. Type II collagen is a major component of hyaline 
cartilage. The fibrillar collagens provide a major component of tissue strength. 
Most of the remaining collagen types are nonfibrillar, the most common of which 
is type IV, a major constituent of all basement membranes. Elastin fibres confer 
an elastic flexibility to tissues. 
In the amorphous matrix, glycosaminoglycans (GAGs), with the exception of 
hyaluronic acid, are found convalently bound to proteins (as proteoglycans). 
Proteoglycans serve as major structural elements of the extracellular matrix; 
some proteoglycans are bound to plasma membranes and appear to be involved 
in adhesiveness and receptor binding. A set of large noncollagenous 
glycoproteins is important in binding cells to the extracellular matrix, including 
fibronectins (the best understood of the noncollagenous glycoproteins), laminins, 
chondronectin and osteonecins. Fibronectins, found  almost ubiquitously in the 
extracellular matrix are synthesized by many different cell types. The circulating 
form, plasma fibronectin, is produced mainly by hepatocytes. Fibronectin’s 
adhesive character makes it a crucial component of blood clots and pathways 
followed by migrating cells. Thus fibronectin-rich pathways guide and promote the 
migration of many cells during embryonic development and wound healing. 
Basement membranes provide mechanical support for resident cell, cell as 
semipermeable barriers between tissue components, and act as regulators of 
cellular attachment, migration, and differentiation. They consist of discrete zone 
of amorphous, noncollagenous glycoprotein matrix (including laminin), 
proteoglycans, and type IV collagen. 
In order to illustrate further the basic concept of ECM and how hierarchical 
organisation in tissues give rise to a wide variety of biological functions three 
examples of tissue are discussed. 
2.1.2. Bone 
Bone tissue is an extremely strong and dense material that is well suited to its 
role in providing load-bearing support and protection for the body. It is largely 
composed of mineral, which is in the form of tiny crystals of impure form of 
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hydroxyapatite, and collagen. The specific composition and organisation of the 
components dictate the mechanical properties of bone [10, 13]. The mineral 
portion is believed to be primarily responsible for the stiffness of the tissue, while 
the collagen dictates the post-yield properties. 
 
 
Fig 2.1 Bone tissue demonstrating 3D architecture, blood supply and innervation. Insert 
magnification of trabeculae demonstrates the microenvironment of osteocytes contained in lacuna 
spaces with interconnecting network of canaliculi.  
 
Bone tissue can be divided into two distinct structural types: (i) compact, or 
cortical bone which is quite dense (porosity of 5-25%) [14], and (ii) cancellous, or 
trabecular bone, which is highly porous (porosity of 40-90%)[4]. Cortical bone is 
largely found in mid-shafts of long bones and is composed of longitudinally 
oriented cylindrical units known as osteons, which are typically 200µm in dimeter, 
10-20mm long, and are composed of concentric lamellae 3-7µm thick [2]. It is the 
orientation of the osteons that give rise to the strong mechanical anisotroipy 
found in cortical bone (i.e. cortical bone is much stiffer and stronger along the 
direction of the osteons compared with the direction transverse to the osteons). 
 15
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At the centre of the osteons are Haversian canals that contain blood vessels; 
these vessels supply the tissue with nutrients via microchannels known as 
canaliculi; a crucial feature for such dense tissue. 
In contrast, the structure of cancellous bone consists of a network of 
interconnecting struts known as trabeculae 50-300µm thick) [2]. The pore space 
of this network is filled with bone marrow. Trabecular bone is also anisotropic, 
and it is believed that the principal direction of the trabecular network, which is 
the direction of greatest stiffness and strength, corresponds to the direction of 
habitual loading. Cancellous bone is found at the ends of long bones (surrounded 
by a layer of cortical bone) and in bones such as the skull and vertebra.  
2.1.3. Artery 
The arterial wall is also a crucial load-bearing tissue that derives its unique 
mechanical properties from its complex organisation of structural proteins and 
cells. However, since it must accommodate the pulsatile output from the heart, it 
must be distensible and, as a result, cannot achieve mechanical strength in the 
same manner as bone tissue. The arterial wall is composed of three distinct 
layers; (i) the intima, which comprises a single layer of endothelial cells that lines 
the inner surface of the vessel; (ii) the media, which is the primary load-bearing 
layer of the vessel; and (iii) the adventitia, which anchors the vessel to the 
surrounding tissue (fig. 2.2). The media is primarily responsible for maintaining 
the vascular tone, or degree of constriction relative to its maximally dilated state, 
and hence the vessel diameter. The media is composed of alternating layers of 
smooth muscle cells (SMCs) embedded in collagen and elastin lamellae, the 
number of which depend on the size of the vessel and its anatomical location 
[15]. Collagen provides the high-strain stiffness and strength to the tissue, while 
the elastin offers low-strain elasticity, which prevents the wall from permanently 
deforming as a result of repeated distension. The collagen and SMCs are 
arranged in a helical pattern around the circumference of the vessel, with the 
direction of the pitch alternating between successive layers. This helical 
arrangement not only provides enhanced circumferential load-bearing properties 
to the tissue, but also imparts torsional stability [16-19] Furthermore, this 
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arrangement of SMCs allows more efficient control of vessel tone (which in turn 
dictates blood pressure and shear stress) as this configuration leads to SMC 
contraction that primarily results in a reduction of the vessel lumen diameter 
rather than its length. 
The high degree of organisation in the arterial wall does not solely serve a 
mechanical purpose. The intima, which can be considered as the biological focal 
point of the vessel wall, is crucial for providing a nonthrombogenic blood-
contacting surface (the underlying media is highly thrombogenic), regulating 
vascular tone, and controlling nutrient and water transport across the vessel wall. 
The adventitia functions primarily to anchor the blood vessel to its surrounding 
tissue, but also supports the microvasculature and nerves that connect to the 
outer layers of the large arteries.  
 
 
Fig 2.2 Anatomy of blood vessels [artery (Lt). and vein (Rt.)] demonstrating its constituent layers 
and 3D architecture. 
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2.1.4. Liver 
Unlike the previous two examples, liver tissue has not inherent mechanical 
function, but organisation of its components is crucial for its ability to function 
properly. The liver is a complex organ that plays a major role in metabolism an 
performs a number of functions including glycogen storage, plasma protein 
synthesis, and drug detoxification [20]. The functional unit of the liver is a 
hexagonal lobule of approximately 2mm in diameter centred around a vein 
(terminal hepatic venule) with arteries and veins providing blood from the 
periphery of the lobule (fig. 2.3). The blood passes from the arteries into 
sinusoids (ducts lined with epithelial cells) where nutrients, metabolites, and 
toxins pass through the epithelium and are processed by the underlying 
hepatocytes. The processed blood is collected in the central before leaving the 
liver. Furthermore, bile ducts run throughout the tissue collecting bile secreted by 
the hepatocytes. The complex organisation of the individual, as well as their 
large-scale organisation throughout the liver in combination with its vascular 
network, is crucial to the organs’ function. 
 
 
 
 
Fig 2.3 Functional anatomy and 3D architecture of liver hexagonal lobule 
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2.1.5. Pancreas 
The pancreas is an elongated organ, light tan or pinkish in colour, which lies in 
close proximity to the duodenum. It is covered with a very thin connective tissue 
capsule which extends inward as septa, partitioning the gland into lobules. The 
bulk of the pancreas is composed of pancreatic exocrine cells and their 
associated ducts. Embedded within this exocrine tissue are roughly one million 
small clusters of cells called the Islets of Langerhans, which are the endocrine 
cells of the pancreas and secrete insulin, glucagon and several other hormones. 
A graphic representation of islets architecture is illustrated in fig. 2.3. 
 
 
Fig 2.3 Functional anatomy and 3D architecture of the pancreas The pancreas is located in the 
abdomen, adjacent to the duodenum (the first portion of the small intestine). A cross-section of the 
pancreas shows the islet of Langerhans which is the functional unit of the endocrine pancreas. 
Encircled is the beta cell that synthesizes and secretes insulin. Beta cells are located adjacent to 
blood vessels and can easily respond to changes in blood glucose concentration by adjusting 
insulin production. Insulin facilitates uptake of glucose, the main fuel source, into cells of tissues 
such as muscle. 
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2.2. Tissue - Biomaterials Interactions 
2.2.1. Cell adhesion to artificial substrates 
The importance of proteins in biomaterials science stems primarily from their 
inherent tendency to deposit on surfaces as a tightly bound adsorbate, and the 
strong influence these deposits have on the subsequent cellular interactions with 
the surfaces. It is thought that the particular properties of surfaces, as well as the 
specific properties of individual proteins, together determine the organisation of 
the adsorbed protein layer, and that the nature of this layer in turn determines the 
cellular response to the adsorbed surfaces. Since the cellular responses largely 
determine the [21]degree of biocompatibility of the material, the properties of 
proteins and their behaviour at interfaces need to be understood by those 
interested in biomaterials. Fig 2.4 illustrates the interaction of a cell with an 
adsorbed protein layer on a solid substrate. 
In order to improve biomaterial performance and hence extend the lifetime of 
implants, it is essential to design surface characteristics that interface optimally 
with select proteins and subsequently with pertinent bone cell types. That is, 
immediately after implantation, proteins will adsorb from plasma to biomaterial 
surfaces to control cell attachment and eventual tissue regeneration (Figure 2.4) 
[22, 23]. Initial protein interactions that mediate cell function depend on many 
biomaterial properties, including chemistry, charge, wettability, and topography 
[22, 23]. Of significant influence for protein interactions is surface roughness and 
energy [24-27], and this represents the promise of nanophase materials in 
implant applications. 
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Fig 2.4 Cell recognition of biomaterial surfaces controlled by initial protein interactions. Initial protein 
interactions can influence cell adhesion and, thus, degree of bone tissue formation on biomaterials. 
Changing material properties will alter protein interactions and influence subsequent cell function. 
(Adapted and redrawn from Schakenraad, J.M., in Biomaterials Science: An Introduction to 
Materials in Medicine, Ratner, B.D., Hoffman,A.S., Schoen, F.S., and Lemmons, J.E., Eds., 
Academic Press, New York, 1996, pp. 133–140.) 
2.2.2. Host reaction to biomaterials  
Inflammation, Wound Healing, and the Foreign Body Reaction 
Inflammation, wound healing, and foreign body response are generally 
considered as parts of the tissue or cellular host response to injury. Table 2.1 lists 
the sequence of these events following injury.  
 
Table 2.1 Sequence of Local Events Following Implantation 
Injury 
Acute Inflammation 
Chronic inflammation 
Granulation Tissue 
Foreign Body Reaction 
Fibrosis 
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From a biomaterials perspective, placing a biomaterial in the in vivo environment 
involves injection, insertion, or surgical implantation, all of which injure tissues or 
organs involved. 
The placement procedure initiates a response to the injury by the body, and 
mechanisms are activated to maintain homeostasis. The degrees to which the 
homeostatic mechanisms are perturbed and the pathophysiologic conditions 
created and resolved are a measure of the host’s reaction to the biomaterial and 
may ultimately determine its biocompatibility. While it is convenient to separate 
homeostatic mechanisms into blood-material or tissue-material interactions, it 
must be remembered that the various components or mechanisms involved in 
homeostasis are present in both blood and tissue and are part of the physiologic 
continuum. Furthermore, it must be noted that host reactions can be tissue-
dependent, organ-dependent, and species-dependent. Obviously, the extent of 
injury varies with the implantation procedure. 
Inflammation is generally defined as the reaction of vascularised living tissue to 
local injury. Inflammation serves to contain, neutralize, dilute, or wall off injurious 
agent or process. In addition, it sets into motion a series of events that may heal 
and reconstitute the implant site through replacement of the injured tissue by 
regeneration of native parenchymal cells, formation of fibroblastic scar tissue, or 
a combination of these two processes. 
Immediately following injury, there are changes in vascular flow, calibre, and 
permeability. Fluid, proteins, and blood cells escapes from the vascular system 
into the injured tissue in a process called exudation. Following changes in the 
vascular system, which also include changes induced in blood and its 
components, cellular events occur and characterise the inflammatory response. 
The effect of this injury and/or biomaterial in situ on plasma or cells can produce 
chemical factors that mediate many of the vascular and cellular responses of 
inflammation. 
Regardless of the tissue or organ into which a biomaterial is implanted, the initial 
inflammatory response is activated by injury to vascularised connective tissue. 
Since blood and its components are involved I the initial inflammatory response, 
blood clot formation and/ or thrombosis also occur. Blood coagulation and 
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thrombosis are generally considered humoral responses and may be influenced 
by other homeostatic mechanisms such as the extrinsic and intrinsic coagulation 
systems, the complement system, the fibrinolytic system, the kinin-generating 
system, and platelets.  
The predominant cell type present in inflammatory repose varies with the age of 
the injury. In general, neutrophils predominate during the first several days 
following injury and then are replaced by monocytes as the predominant cell type. 
Three factors account for this change in cell type: neutrophils are shorted lived 
and disintegrate and disappear after 24-48 hours; neutrophil emigration is of 
short duration; and chemotactic factors for neutrophil migration are activated 
early in the inflammatory response. Following emigration from the vasculature, 
monocytes differentiate into macrophages and these cells are very long lived (up 
to months). Monocyte emigration may continue for days to weeks, depending on 
the injury and implanted biomaterial, and chemotactic factors for monocytes are 
activated over longer periods of time. 
The sequence of events following implantation of a biomaterial is illustrated in fig 
2.5.  
 
 
Fig 2.5 Schematic representation of the time course of the foreign body reaction to an implanted 
“biocompatible” material. 
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The size, shape and chemical and physical properties of biomaterials may be 
responsible for the variations in the intensity and duration of the inflammatory or 
wound-healing process. Thus, intensity and/or time duration of the inflammatory 
reaction may characterize the biocompatibility of a biomaterial. 
While injury initiates the inflammatory response, the chemicals released from 
plasma, cells and injured tissue mediate the response. Important classes of 
chemical mediators of inflammation are presented in Table 2.2. Several points 
must be noted in order to understand the inflammatory response and how it 
relates to biomaterials. First, although chemical mediators are classified on a 
structural or functional basis, different mediator systems interact and provide a 
system of checks and balances regarding their respective activities and functions. 
Second, chemical mediators are quickly inactivated or destroyed, suggesting that 
their action is predominantly local (i.e. at the implant site). Third, generally the 
lysosomal proteases and oxygen-derived free radicals produce the most 
significant damage or injury. These chemical mediators are also important in the 
degradation of biomaterials. 
 
2.2.2.1. Acute Inflammation 
Acute inflammation is of relatively short duration, lasting from minutes to days, 
depending on the extent of the injury. Its main characteristics are the exudation of 
fluid and plasma proteins (oedema) and the emigration of leukocytes 
(predominantly neutrophils). Neutrophils and other motile white cells emigrate or 
move from the blood vessels to the perivascular tissues and the injury (implant) 
site. Leukocytes emigration is assisted by “adhesion molecules” present on 
leukocyte and endothelial surfaces. The surface expression of these adhesion 
molecules can be induced, enhanced, or altered by inflammatory agents and 
chemical mediators. White cell emigration is controlled, in part, by chemotaxis, 
which is the unidirectional migration of cells along a chemical gradient. A wide 
variety of exogenous and endogenous substances have been identified as 
chemotactic agents. Specific receptors for chemotactic agents on the cell 
membranes of leukocytes are important in the emigration or movement of 
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leukocytes. These and other receptors may also play a role in the activation of 
leucocytes. Following localization of leucocytes at the injury site (implant) site, 
phagocytosis and the release of enzymes occur following neutrophils and 
macrophages. The major role of neutrophils in acute inflammation is to 
phagocytose micro-organisms and foreign materials. Phagocytosis is seen as a 
three-step process in which the injurious agent undergoes recognition and 
neutrophil attachment, engulfment, and killing or degradation. In regard to 
biomaterials, engulfment and degradation may or may not occur, depending on 
the properties of the biomaterial. 
Although biomaterials are not generally phagocytosed by neutrophils or 
macrophages because of the disparity of size, (i.e., the surface of the biomaterial 
is greater than the size of the cell), certain events in phagocytosis may occur. 
The process of recognition and attachment is expedited when the injurious agent 
is coated by naturally serum factors called “opsonins.” The two major opsonins 
are immunoglobulin G (IgG) and the complement-activated fragment, C3b. both 
these plasma-derived proteins are known to adsorb to biomaterials, and 
neutrophils and macrophages have corresponding cell membrane receptors for 
these opsonization proteins. These receptors may also play a role in the 
activation of the attached neutrophil or macrophage. Owing to the disparity in size 
between the biomaterial surface and the attached cell, frustrated phagocytosis 
may occur. This process does not involve engulfment of the biomaterial but does 
cause the extracellular release of leukocyte products in an attempt to degrade the 
biomaterial. 
Henson [28] has shown that neutrophils adherent to complement-coated and 
immunoglobulin-coated nonphagocytosable surfaces may release enzymes by 
direct extrusion or exocytosis from the cell. The amount of enzyme released 
during this process depends on the size of the polymer particle, with larger 
particles inducing greater amounts of enzyme release. This suggests that the 
specific mode of cell activation in the inflammatory response in tissue depends 
upon the size of the implant and that a material in a phagocytosable form (i.e., 
powder or particulate) may provoke a different degree of inflammatory response 
than the same material in a nonphagocytosable form (i.e., film). 
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TABLE 2.2 Important Chemical mediators of Inflammation Derived from Plasma, Cells, 
and Injured Tissue 
Mediators Examples 
Vasoactive amines Histamines, serotonin 
Plasma proteases 
• Kinin system 
• Complement system 
• Coagulation/fibrinolytic system 
 
Bradykinin, kallikrein 
C3a, C5a, C3b, C5b – C9 
Fibrin degradation products; activated 
Hageman factor (FXIIA) 
Arachidonic acid metabolites 
• Prostaglandins 
• Leukotrienes 
 
PGI2, TxA2 
HETE, Leukotriene B4
Lysosomal proteases Collagenase, elastase 
Oxygen-derived free radicals H2O2, Superoxide anion 
Platelet activating factors Cell membrane lipids 
Cytokines Interleukin 1 (IL-1); tumour necrosis 
factor (TNF) 
Growth factors Platelet derived growth factor 
(PDGF); fibroblast growth factor 
(FGF); transforming growth factor 
(TGF-α or TGF-β 
 
 
2.2.2.2. Chronic inflammation 
Chronic inflammation is less uniform histologically than acute inflammation. In 
genera, chronic inflammation is characterized by the presence of macrophages, 
monocytes, and lymphocytes, with the proliferation of blood vessels and 
connective tissue. It must be noted that many factors can modify the course and 
histological appearance of chronic inflammation. 
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Persistent inflammatory stimuli lead to chronic inflammation. While the chemical 
and physical properties of biomaterials in themselves may lead to chronic 
inflammation, motion in the implant site by the biomaterial my also produce 
chronic inflammation. The chronic inflammatory response to biomaterials is 
usually of short duration and is confined to implant site. The presence of 
mononuclear cells, including lymphocytes and plasma cells, is considered chronic 
inflammation, while the foreign body reaction with the development of granulation 
tissue is considered the normal wound healing response to implanted 
biomaterials.  
Lymphocytes and plasma cells are involved principally in the immune reactions 
and are key mediators of antibody production and delayed hypersensitivity 
response. Their roles in non-immunologic injuries and inflammation are largely 
unknown. Little is known regarding humoral immune responses and cell-
mediated immunity to synthetic biomaterials. The role of macrophages must be 
considered in the possible development of immune responses to synthetic 
biomaterials. Macrophages process and present the antigen to 
immunocompetent cells and thus are key mediators in the development of 
immune reactions. 
Monocytes and macrophages belong to the mononuclear phagocytic system 
(MPS), also known as the reticuloendothelial system (RES). These systems 
consist of cells in the bone marrow, peripheral blood, and specialized tissues. 
The specialized cells in these tissue may be responsible for systemic effects in 
organs or tissue secondary to the release of components or products from 
implants through various tissue-material interaction (e.g., corrosion products, 
wear debris, degradation products) or the presence of implants (e.g., 
microcapsule or nanoparticle drug delivery systems). 
The macrophage is probably the most important cell in chronic inflammation 
because of the great number of biologically active products it can produce. 
Important classes of products produced and secreted by macrophages include 
neutral proteases, chemotactic factors, arachidonic acid metabolites, reactive 
oxygen metabolites, complement components, coagulation factors, growth-
promoting factors, and cytokines. 
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Growth factors such as platelet-derived growth factor (PDGF), fibroblast growth 
factor (FGF), transforming growth factor-β (TGF-β), TFG-α/epidermal growth 
factor (EGF), and interleukin-1 (IL-1) or tumour necrosis factor (TNF) are 
important to the growth of fibroblasts and blood vessels and the regeneration of 
epithelial cells. Growth factors released by activated cells can stimulate 
production of a wide variety of cells; initiate cell migration; differentiation, and 
tissue remodelling, and may be involved in various stages of wound healing. 
 
2.2.2.3. Granulation tissue 
Within one day following implantation of a biomaterial (i.e., injury), the healing 
response is initiated by the action of monocytes and macrophages. Fibroblasts 
and vascular endothelial cells in the implant site proliferate and begin to form 
granulation tissue, which is the specialized type of tissue that is the hallmark of 
healing inflammation. Granulation tissue derives its name from the pink, soft 
granular appearance on the surface of healing wounds and its characteristic 
histological features include the proliferation of new small blood vessels and 
fibroblasts. Depending on the extent of injury, granulation tissue may be seen as 
early as 3-5days following implantation of the biomaterial.  
The new small vessels are formed by budding or spouting of pre-existing vessels 
in the process known as neovascularisation or angiogenesis. This process 
involves proliferation, maturation, and organization of endothelial cells into 
capillary tubes. Fibroblasts also proliferate in developing granulation tissue and 
are active in synthesizing collagen and proteoglycans. In the early stages of 
granulation tissue development, proteoglycans predominate but later collagen, 
especially type II collagen, predominates and forms the fibrous capsule. Some 
fibroblasts in developing granulation tissue may have the features of smooth 
muscle cells. These cells are called myofibroblasts and are considered to be 
responsible for the wound contraction seen during the development of 
granulation tissue. Macrophages are almost always present in granulation tissue. 
Other cells may also be present if chemotactic stimuli are generated. 
 
Scientific Background 29
 
The wound healing response is generally dependent on the extent or degree of 
injury or defect created by the implantation procedure. Wound healing by primary 
union or first intention is the healing of clean, surgical incisions in which the 
wound edges have been approximated by surgical sutures. Healing under these 
conditions occurs without significant bacterial contamination and with a minimal 
loss of tissue. Wound healing by secondary union or second intention occurs 
when there is a large tissue defect that must be filled or there is extensive loss of 
cells and tissue. In wound healing by secondary intention, regeneration of 
parenchymal cells cannot completely reconstitute the original architecture and 
much larger amounts of granulation tissue are formed that result in lager areas of 
fibrosis or scar formation. 
Granulation tissue is distinctly different from granulomas, which are small 
collections of modified macrophages called epithelioid cells that are usually 
surrounded by a rim of lymphocytes. Langhan’s or foreign body-type giant cells 
may surround nonphagocytosable particulate materials in granulomas. Foreign 
body giant cells are formed by the fusion of monocytes and macrophages in an 
attempt to phagocytose the material. 
 
2.2.2.4. Foreign body reaction. 
The foreign body reaction to biomaterials is composed of foreign giant cells and 
the components of granulation tissue. These consist of macrophages, fibroblasts, 
and capillaries in varying amounts, depending upon the form and topography of 
the implanted material. Relatively flat and smooth surfaces such as those found 
on breast prostheses have a foreign body reaction that is composed of a layer of 
macrophages one to two cells thickness. Relatively rough surfaces such as those 
found o the outer surfaces of expanded poly(tetrafluoroethylene) (ePTFE) 
vascular prostheses have a foreign body reaction composed of macrophages and 
foreign body giant cells at the surface. Fabric materials generally have a surface 
response composed of macrophages and foreign body giant cells, with varying 
degrees of granulation tissue subjacent to the surface response. 
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As previously discussed, the form and topography of the surface of the 
biomaterial determines the composition of the foreign body reaction. With 
biocompatible materials, the composition of the foreign body reaction in the 
implant site may be controlled by surface properties of the biomaterial, the form 
of the implant, and the relationship between the surface area of the biomaterial 
and the volume of the implant. For example, high surface- to volume implants 
such as fabrics or porous materials will have higher ratios of macrophages and 
foreign body giant cells in the implant site than smooth surface implants, which 
will have fibrosis as a significant component of the implant site. 
The Foreign body reaction consisting mainly of macrophages and/or foreign giant 
cells may persist at the tissue-implant interface for the lifetime of the implant. 
Generally, fibrosis (i.e., fibrous encapsulation) surrounds the biomaterials or 
implant with its interfacial foreign body reaction, isolating the implant and foreign 
body reaction from local issue environment. Early in the inflammatory and wound 
healing response, the macrophages are activated upon adherence to the material 
surface. 
While it is generally considered that the chemical and physical properties of the 
biomaterial are responsible for macrophage activation, the subsequent events 
regarding the activity of macrophages at the surface are not clear. Tissue 
macrophages, derived from circulating blood monocytes, may coalesce to form 
multinucleated foreign body giant cells. It is not uncommon to see very large 
foreign body giant cells containing large numbers of nuclei on the surface of 
biomaterials. While these foreign body giant cells may persist for the lifetime of 
the implant, it is not known if they remain activated, releasing their lysosomal 
constituents, or become quiescent. 
 
2.2.2.5. Fibrosis and fibrous encapsulation 
The end-stage healing response to biomaterials is generally fibrosis or fibrous 
encapsulation. However, there may be exceptions to this general statement (e.g., 
porous materials inoculated with parenchymal cells or porous materials implanted 
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into bone. As previously stated, the tissue response to implants is part dependent 
upon the extent of injury or defect created in the implantation procedure. 
Repair of implant sites can involve two distinct processes: regeneration, which is 
replacement of injured tissue by parenchymal cells of the same type, or 
replacement by connective tissue that constitutes the fibrous capsule. These 
processes are generally controlled by either (1) the proliferative capacity of the 
cells in the issue or organ receiving the implant and the extent of injury as it 
relates to destruction, or, (2) persistence of tissue the tissue framework of the 
implant site. 
The regenerative capacity of cells allows them to be classified into three groups: 
labile, stable (or expanding) and permanent (or static) cells. Labile cells continue 
to proliferate throughout life, stable cells retain his capacity but do not normally 
replicate; and permanent cells cannot reproduce themselves after birth. Perfect 
repair with restitution of normal structure can theoretically only occur in tissue 
consisting of stable and labile cells, while all injuries to tissues composed of 
permanent cells may give rise to fibrosis and fibrous capsule formation with very 
little restitution of the normal tissue or organ structure. Tissues composed to 
permanent cells (e.g., nerve cells, skeletal muscle cells, cardiac muscle cells) 
most commonly undergo an organisation of inflammatory exudate, leading to 
fibrosis. Tissues composed of stable cells (e.g., parenchymal cells of the liver, 
kidney, and pancreas); mesenchymal cells (e.g., fibroblasts, smooth muscle cells, 
osteoblasts, and chondroblasts); and vascular endothelial and labile cells (e.g., 
epithelial cells and lymphoid and haematopoietic cells) may also follow this 
pathway to fibrosis or may undergo resolution of the inflammatory exudate, 
leading to restitution of the normal tissue structure. 
The condition of the underlying framework or supporting stroma of the 
parenchymal cells following an injury plays an important role in the restoration of 
normal tissue structure. Retention of the framework may lead to restitution of the 
normal tissue structure while destruction of the framework most commonly leads 
to fibrosis. It is important to consider the species-dependent nature of the 
regenerative capacity of cells. For example, cells from the same organ or tissue 
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but from different species may exhibit different regenerative capacities and/or 
connective tissue repair. 
Following injury, cells may undergo adaptations of growth and differentiation. 
Important cellular adaptations are atrophy (decrease in cell size or function), 
hypertrophy (increase in cell size), hyperplasia (increase in cell number) and 
metaplasia (change in cell type). Other adaptations include a change by cells 
from producing one family of proteins to another (phenotypic change), or marked 
overproduction of protein. This may be the case in cells producing various types 
of collagens and extracellular matrix proteins in chronic inflammation and fibrosis. 
Causes of atrophy may include decreased workload (e.g., stress-shielding by 
implants), and diminished blood supply and inadequate nutrition. (e.g., fibrous 
capsules surrounding implants). 
Local and systemic factors may play a role in the wound healing response to 
biomaterials or implants. Local factors include he site (tissue or organ) of 
implantation, adequacy of blood supply and potential for infection. Systemic 
factors nay include nutrition, haematological derangements, gluco-cortical 
steroids, and pre-existing diseases such as atherosclerosis, diabetes, and 
infection. 
Finally, the implantation of biomaterials or medical device may be best viewed at 
present from the perspective that the implant provides an impediment or 
hindrance to appropriate tissue or organ regeneration and healing. Given our 
current inability to control the sequence of events following injury in the 
implantation procedure, restitution of normal tissue structures with function is 
rare.  
Current studies directed toward developing a better understanding of the 
modification of the inflammatory process, stimuli providing for appropriate 
proliferation of permanent and stable cells, and the appropriate application of 
growth factors may provide keys to the control inflammation, wound healing, and 
fibrous encapsulation of biomaterials. 
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2.2.3. Mathematical Model of Oxygen Diffusion Across a 
Biomembrane 
Oxygen is very often the limiting nutrient in reconstructed tissues. The oxygen 
requirements vary largely with cell type. Among the cells commonly use in 
bioartificial systems, hepatocytes and pancreatic islet cells are particularly 
sensitive to the availability of oxygen. Oxygen is required for efficient cell 
attachment and the spreading to planar surfaces as well as microcarriers [29, 30]. 
Based on a simple mathematical model, we can estimate the critical distance at 
which the oxygen concentration at the cell surface becomes limiting (this 
concentration is arbitrary set equal to Km) if an unstirred aqueous layer is placed 
between the gas phase (air) and a confluent monolayer of cells [31]. In the case 
of a confluent monolayer of hepatocytes (2 x 105 cells/cm2), this distance is 
0.95mm. Thus, in a first approximation, a successful bioartificial liver system 
containing hepatocytes will have to keep the diffusional distance between the 
oxygen-carrying medium and cells to below 1mm (assuming a confluent cell 
monolayer on the surface). Figure 2.6 was used to estimate the maximum half 
thickness of a cell mass surrounded by a membrane or external diffusion barrier 
before the nutrient concentration in the centre falls below the Michaelis-Menten 
constant for nutrient uptake, a sign of nutrient limitation at the cellular level. 
Oxygen uptake parameters for different cell types are given by Fleischaker [32]. 
Values for hepatocytes and pancreatic islets have also been reported [31, 33, 
34]. For illustrative purposes cylindrical hepatocytes aggregates were used as an 
example. The following was assumed: no external barrier (R1/R0) = 1; medium 
saturated with air at 37oC at the aggregate surface (160mmHg = 190nmol/cm3); 
diffusivity of oxygen in aggregates (Do) similar to that of water (2 x 10-5cm2/s); a 
packed cell mass (given a cell diameter of approximately 20µm, this corresponds 
to 1.25 x 108 cells/cm3). The oxygen uptake parameters for hepatocytes were 
µmax 0.4nmol/106cells/s (thus 50nmol/cm3/s for the above cell concentration) and 
Km = 0.5 mmHg (e.g., 0.6nmol/cm3). We obtain C1/Km = Co/Km =320, (µmax 
R2)/DoKm) =724, 1370 and 2010 for the slab, cylindrical and spherical geometries, 
respectively, and thus the corresponding maximum half thickness obtained are R 
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= 132, 181, and 220 µm, respectively. We now consider the case where there is 
an 100µm thick membrane around a cylindrical cell aggregate assuming that the 
diffusivity of oxygen in the membrane (D1) is the same as in the cell mass. An 
aspect ratio (α) must be assumed and values of Co/Km, (µmaxR2)/DoKm), and Ro 
are calculated. R1 is then obtained from the assumed aspect ratio. Calculations 
must be performed with several aspect ratios until the difference R1 – Ro equates 
the membrane thickness. It was found that α =0.6 generates Co/Km = 141, 
(µmaxR2)/(DoKm) = 622, Ro = 122 µm. For a cylinder, = Do/D1 1n(R1/Ro), and thus in 
this case R1 = 222µm. Thus, the maximum half-thickness of the cell mass is 
122µm, as compared to 181 µm in the absence of the membrane.  
 
These estimates can be used as first guidelines to design a bioartificial liver, and 
they clearly suggest that the thickness of the cell mass must be limited to a few 
hundred microns to prevent the formation of an anoxic core.  
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Figure 2.6 Collection to predict the maximum half-thickness R of a cell mass surrounded by a shell 
of thickness R1- Ro without nutrient limitation, assuming that diffusion is the only transport 
mechanism involved. A: The nutrient concentration at the surface of the cell mass normalized to the 
Michaelis-Menten constant for the nutrient by cells (Co/Km) is obtained from the normalized bulk 
nutrient concentration (C1/Km), and the aspect ratio of the system (R1/Ro).Do, D1 are the diffusivities 
for nutrient within the cell mass and the external diffusion barrier, respectively. The partition 
coefficient between the cell mass and the surrounding shell is assumed to be equal to 1. 
B. The half thickness R for which C/Km = 1 in the centre (R=0) is obtained from the value of the y-
axis corresponding to Co/Km, knowing, in addition to the parameters listed above, the maximum 
nutrient uptake rate by cells (µmax). If Km is unknown, a zero order approximation may be used, in 
which case Km is set arbitrarily so that C1/Km falls in the linear portion of the curve in A. In B, Ro is 
obtained using the line labelled “0th order approximation,” and corresponds to the half thickness R 
for which C = 0 at the centre (R = 0). 
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Table 2.2 Maximum Oxygen Uptake Rates of Cells Used in Tissue 
Reconstruction 
 
Cell Type µmax (nmol/106cells/s) K0.5a 
(mmHg) 
Reference 
Sp2/0-derived 
mouse hybridoma 
0.053 0.28 [35] 
Hepatocytes 0.38 (day 1, single gel) 
0.25 (day 3, single gel) 
5.6 
3.3 
Oxyvice 
paper 
Pancreatic Islet 
cells 
25.9 nmol/cm3/s (100mg/dl 
glucose) 
46.1 nmol/cm3/s (300mg/dl 
glucose) 
0.44 [34] 
a Oxygen tension for which the oxygen uptake rate equals half the maximum. 
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CHAPTER 
___________________________________ 
3 
3. Tissue Engineering 
This chapter reviews the state-of-the art in tissue engineering. Current obstacles and 
challenges are highlighted. 
 
Tissue engineering is ‘‘an interdisciplinary field that applies the principles of 
engineering and of life science towards the development of biological substitutes 
that restore, maintain, or improve tissue or organ function [36]’’. In a classical 
sense, tissue engineering implies the use of tissue or organs specific cells for 
seeding a scaffold ex vivo and holds the promise of one day replacing living 
tissue with living tissue designed and fabricated to meet the individual defects 
[36, 37]. This approach is convincing based on several observations for the 
behaviour of tissues and cells: Most tissues undergo remolding, isolated cells 
tend to form the appropriate tissue structures in vitro under favourable conditions, 
isolated cells require a template to guide their organization into a proper 
architecture. 
Tissue engineering focuses on providing a 3D environment, or scaffold, for cell 
attachment and growth, and assumes that by simulating the in vivo environment, 
cells can be coaxed into creating a desired tissue type or function. Therefore 
scaffold design must mimic, as far as possible, the structure and biological 
function of the gold standard scaffold; the extracellular matrix (ECM). 
The ideal requirements of these scaffolds are that they provide mechanical 
support, are biocompatible, are non biodegradable over a predetermined period 
of time, can be molded into the desired shape, are easy to sterilize and can allow 
cell attachment, viability, proliferation and differentiation. The ultimate aim of 
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tissue engineering is to make a 3D cell containing scaffold that can be implanted 
in the body to cure or repair a defect. 
3.1. Conventional Scaffolds 
Biomedical implants have been used since ancient times – for example, a 
Brazilian group recently reported that the ancient Incas successfully used gold 
plates to repair cranial defects [3]. Until the last few decades of the 20th century, 
the criteria used in choosing materials for implants has fundamentally changed 
very little and usually implant materials were chosen that were functional because 
of their inertness. Since the discovery in the 1960s that some glass ceramics 
actively bond to living bone, however, the focus has shifted away from inert 
materials and toward materials that are bioactive – those that deliberately elicit a 
specified response from the body. Currently, most scaffolds provide a three-
dimensional environment in which tissue can grow and develop, so that it is able 
to reproduce the functions of the tissue it is intended to replace. Some scaffolds 
may be designed to be implanted without any cellular component [38] – instead 
they are designed to encourage tissue ingrowth and de novo tissue synthesis in 
vivo – while most are intended to have some kind of cellular component 
engineered in vitro before implantation. The latter strategies require that cells 
have access to nutrients and space to grow. For this reason most scaffolds, 
regardless from which material they are made, are constructed with some kind of 
porous network and cultured with cells in a manner that encourages nutrient 
transport. For instance, inorganic materials such as bioactive glass and calcium 
phosphates have been extensively been used for bone tissue engineering 
because of the similarities to and their ability to bond with bone’s natural mineral 
backbone. Bioactive glasses can be sintered in powder form to create porous 
networks [39], or, when in solution, can simply be “foamed” using soap and gelled 
to make sol-gels [40]. Similarly, porosity can be engineered into polymers, such 
as polyesters (which have the advantage of being biodegradable), either by 
foaming the polymer solution [41] or by molding the dissolved polymer around 
lumps of another material such as salt, allowing the polymer to harden and then 
 
Tissue Engineering 39
 
leaching out the salt with water [42]. Porous networks can also be engineered 
into natural molecules – for example, collagen gels can be freeze-dried before 
cell seeding [43]. 
Alternatively, hydrogels can be used as scaffolds for cell growth and cell delivery. 
Since the gelling process is often nontoxic, cells can be introduced into the 
solution prior to gelation. In the case of alginate, a natural polymer made up of 
chains of guluronic and manuronic acid, calcium is usually added to cell/gel 
solutions, which crosslinks these chains and hardens the gel [25]. Likewise, 
collagen gels can be hardened by altering the pH of the solution[44, 45] and 
poly(ethene) glycol can be solidified using light [46]. Hydrogels have different 
mechanical properties from other scaffolds, so the material must be selected on 
the basis of its properties, keeping in mind the intended application. 
 
But all of these scaffolds have their disadvantages. Inorganic scaffolds such as 
ceramics and glasses tend to be too brittle and weak to be used in load-bearing 
applications, and even bioactive glasses, discovered more than 30 years ago, are 
limited to non-load-bearing applications such as the replacement of small bones 
in the middle ear [47]. Artificial polymers, on the other hand, may be viewed by 
the body as foreign material because they lack sticky surface molecules for cell 
adhesion. Their degradation products are, in the case of polyesters, acidic, and 
though not directly toxic, may create a possibly unphysiological acidic 
microenvironment. This is particularly important and often overlooked in bone 
tissue engineering – the natural mechanism by which bone is degraded in vivo by 
osteoclasts involves the formation of an acidic microenvironment! Collagen may 
be a better bet in this case, as the natural mechanism of bone formation involves 
the mineralization of a collagen scaffold created by osteoblasts – unsurprisingly 
collagen scaffolds are readily mineralized in tissue engineering experiments [48].  
Another problem with porous scaffolds is that because cells are seeded onto the 
internal porous matrix of the scaffold it becomes arguable whether the cells 
experience a truly three dimensional environment – they merely ‘see’ a slightly 
curved two dimensional surface. This can be solved to some extent by 
decreasing the pore size and adding surface texture, or embedding cells in a soft 
 39
40 Tissue Engineering 
 
extracellular matrix, but then problems arise as to how to keep deeply embedded 
cells supplied with nutrients.  
3.2. Cell Sources in Tissue Engineering: The 
Promise of Stem Cells 
Cells play a crucial role to tissue regeneration and repair due to their 
characteristics of proliferation and differentiation, cell-to-cell interaction, 
biomolecular production, and extracellular matrix formation. The sources of cells 
used in tissue engineering can be autologous, allogeneic, or xenogeneic. Ideal 
donor cells for tissue engineering would be those that are easily accessible, that 
can easily expand without permanently altering the phenotype and function and 
without transmitting species-specific pathogens, that are multipotent to 
differentiate or transdifferentiate into a variety of tissue- or organ-specific cells 
with specialized function, and that have the least immunologic response. Some 
cells, such as keratinocytes, fibroblasts, chondrocytes, endothelial cells, smooth 
muscle cells or skeletal muscle satellite cells, proliferate rapidly. They are good 
tissue-specific cell sources for tissue engineering. However, other cells, such as 
hepatocytes or adult cardiomyocytes, proliferate slowly or not at all. Therefore, 
alternative sources of cells are needed. 
 
Recent advances in stem cell biology have had a marked impact on the progress 
of tissue engineering [49]. Stem cells, which are capable of self-renewal and 
differentiation into various cell lineages, hold great promise for treating affected 
tissue in which the source of cells for repair is limited or not readily accessible. 
Cells derived from human embryonic blastocysts (after undifferentiated 
proliferation in vitro for 4-5 months) still maintain the developmental potential to 
form trophoblast and derivatives of all 3 embryonic germ layers, including gut 
epithelium (endoderm); cartilage, bone, smooth muscle, and striated muscle 
(mesoderm); and neural epithelium, embryonic ganglia, and stratified squamous 
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epithelium (ectoderm) [50]. Although these cell lines should be useful in human 
regenerative medicine, the ethical and legal issues are still under debate. 
3.3. Scaffold and Stem Cells 
Stem cells, of course, are reliant on the extracellular environment not only to 
survive but also to develop into a functional tissue. So increasingly, tissue 
engineers are beginning to use the composition of scaffolds to persuade stem 
cells to differentiate. Arinzeh et al. [51] have shown that adjusting the ratio of 
hydroxyapatite to tri-calcium phosphate could influence the degree to which 
osteogenic differentiation of MSCs occurs, while others have begun to engineer 
bioactive factors into porous scaffolds. For instance, Kim et al. [52] have created 
a polyester scaffold that slowly exudes vitamin C and β-glycerophosphate and 
demonstrated an increase in osteogenesis from MSCs, while Yang et al. [53] 
have demonstrated increased osteogenic differentiation in a polylactic acid (PLA) 
scaffold spiked with a bone-specific growth factor. Alternatively, mechanical force 
can be used to stimulate differentiation – Altman et al. [54] have recently shown 
that applying a mechanical force to a collagen-gel scaffold can encourage MSCs 
to differentiate into ligament tissue. 
 
Micro- and nanopatterned scaffolds have been investigated less well in regard to 
stem cells, although two recent studies highlight their attractiveness. Silva and 
colleagues [55] included a five amino acid, laminin-specific cell-binding domain 
(which binds to specific integrins on cell surfaces) at the hydrophilic head of their 
amphiphiles, and showed that neural stem cells could be induced to differentiate 
into neurons when cultured within the network. In contrast, cells grown in control 
scaffolds without the laminin-specific domain or on two-dimensional tissue culture 
plastic coated with laminin solution differentiated much less. This was 
hypothesized to be largely as a result of the density of the cell-binding ligands to 
which the cells were exposed, indicating clearly the importance of extracellular 
matrix in influencing cell function. In a similar study, Hosseinkhani et al. [56] 
replaced the laminin-specific domain in the amphiphilic molecule with the amino 
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acid sequence, arginine-glycine-aspartate (RGD), a common cell-binding domain 
in many extracellular matrix proteins, especially collagen. They then showed that 
the differentiation of MSCs to osteoblasts is significantly enhanced compared 
with amphililic nanofibers without this sequence on to two-dimensional controls. 
 
So far, remarkably few studies have been published on the effect of three-
dimensional environments and scaffolds on ESC differentiation. In two rare 
examples, Levenberg and colleagues [57, 58] have shown that human ESCs 
embedded in an extracellular matrix gel called Matrigel can be differentiated in 
three dimensions on conventional polyester scaffolds. In these cases, several 
structures that resemble primitive tissues were generated, depending on the 
content of the growth medium. The authors also show that tissues grown in three 
dimensions express higher levels of differentiation-associated proteins than those 
on coated two-dimensional surfaces. Interestingly, another group has recently 
reported that the chondrogenic differentiation of human ESCs in a PEG hydrogel 
is dependent upon whether or not the hydrogel contains adhesive RGD sites, 
illustrating the importance of the cell matrix and microenvironment in ESC 
differentiation [59]. 
 
The use of more novel, patterned scaffolds should provide ESC biologists with an 
important new tool to stimulate and model differentiation in vitro. . In this way, 
scaffolds could play a role in directing tissue organization, not only with the aim of 
producing tissue for transplant but also for studying differentiation in vitro. 
Similarly, ESCs could be compartmentalized within scaffolds to study cell-cell 
interactions and their effect on cell differentiation and tissue formation. Such 
scaffolds will undoubtedly find exciting applications in the study of ESC 
differentiation. 
3.4. Angiogenesis 
One vital requirement for tissue engineered grafts to survive is the sufficient 
supply of oxygen and nutrients and removal of carbon dioxide and waste. Both 
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the supply and removal process involve the transport of substances in the tissue 
possibly in all forms, gas, liquid, and solid. Transport in tissue engineering has 
two main issues: to design tissue with a well perfused transport network and to 
create tissues that would have the function of transport, such as blood vessels. 
To properly perfuse large organs, such as kidney and liver, diffusion and 
convection alone cannot meet the requirements. A well-established vascular 
network is essential. However, techniques to grow a blood vessel network 
throughout the tissue have yet to be developed.  
 
Using nanofabrication, different size scale textures and structures can be 
obtained from a few nanometers to tens of micrometers. These structures are 
good substrates for learning the endothelial cell behaviors on different structures. 
For example, Dike et al. showed that endothelial cells could switch between 
proliferation, apoptosis, and differentiation, when attached on different size scale 
textures and vascular-like tubular structures could form on certain texture range 
surfaces [60]. Kaihara et al. [37] applied micromachining to generate branched 
channels to promote vascular formation and ultimately to enhance the transport 
in tissue-engineered liver. Moldovan and Ferrari [61] developed a silicon-based 
“angiogenesis assistant device”, which is a nanofilter-based, drug delivery silicon 
capsules. 
The nanofilter with controlled size ranging from 10 to 200 nm for angiogenic 
growth factor delivery is jointed with a millimeter-scale silicon frame with an 
endothelial cell coating for blood compatibility and vascularization. The nanofilter 
is created with micromachining and sacrificial layer techniques. This device would 
possess several advantages in both research and clinical applications, such as a 
controllable delivery if there is a combined sensor and remote control device in 
the design, a supply of endothelial cells for better blood compatibility, a delivery 
of angiogenic factors for improved vascularization, and ease ofimplantation. 
 
The microscopic networked tubes with branches, which mimic the circulatory 
system in the body, can be designed by computer and fabricated with 
nanotechnology. Kaazempurmofrad’s [62] approach is to create two half-pipes on 
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silicone, which serves as a mold for making degradable polymer tubes, using 
nanofabrication techniques. This technique has potential applications in tissue 
engineering liver and kidney, which require a significant amount of blood vessels 
to provide oxygen and nutrients to the engineered grafts. 
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CHAPTER 
___________________________________ 
4 
4. Nanotechnology in Biomaterials Science 
This chapter discusses the state of the art of nanotechnology in biomaterials science. It 
highlights how nanotechnology is providing the science and technology for the 
development of next generation biomaterials which simulate the structural properties and 
chemical characteristics of natural extra cellular matrices. Current research efforts to 
create nanoscale surfaces features using ceramics, metals, polymers, and composites are 
reviewed. 
4.1. Nanotechnogoly in biomaterials  
The emergence of micro- and nanoscale science and engineering has provided 
new avenues for engineering materials with macromolecular and even down to 
molecular-scale precision, leading to diagnostic and therapeutic technologies that 
will revolutionize the way health care is administered. Biomaterials have evolved 
from off-the-shelf products (e.g., Dacron for vascular grafts) to materials that 
have been designed with molecular precision to exhibit the desired properties for 
a specific application, often mimicking biological systems [63, 64] 
Controlling interactions at the level of natural building blocks, from proteins to 
cells, facilitates the novel exploration, manipulation, and application of living 
systems and biological phenomena. Nanostructured tissue scaffolds and 
biomaterials are being applied for improved tissue design, reconstruction, and 
reparative medicine [37, 65-67]. Nano- and micro-arrays have been established 
as the preferred method for carrying out genetic and other biological (e.g., drug 
discovery) analysis on a massive scale [68]. Natural nanopores [69, 70] and 
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synthetic nanopores of tailored dimensions [71, 72] are probing, characterizing, 
and sequencing biological macromolecules and have demonstrated the 
possibility to analyze the structure of individual macromolecules faster and 
cheaper [10]. Self-assembly is being applied to create new biomaterials with well-
ordered structures at the nanoscale, such as nanofiber peptide and protein 
scaffolds [73]. In addition, polymer networks with precisely engineered binding 
sites have been created via molecular imprinting, where functional monomers are 
preassembled with a target molecule and then the structure is locked with 
network formation [74]. 
In medical diagnostics, the speed and precision with which a condition is 
detected directly impacts the prognosis of a patient. Point-of-care (POC) 
diagnostic devices, which enable diagnostic testing (in vivo or ex vivo) at the site 
of care, can enhance patient outcomes by substantially abbreviated analysis 
times as a result of the intrinsic advantages of the miniature device and by 
eliminating the need for sample transport to an on-site or off-site laboratory for 
testing. The development of micro or miniaturized total analysis systems (μ-TAS), 
also referred to as lab-on-a-chip devices, has profoundly impacted the 
corresponding development of POC diagnostic devices. These μ-TAS devices 
integrate microvalves, micropumps, micro-separations, microsensors, and other 
components to create miniature systems capable of analysis that typically 
requires an entire laboratory of instruments. Since being introduced as a novel 
concept for chemical sensing devices [75], μ-TAS devices have been applied as 
innovative biological devices [76] and POC diagnostic devices [77, 78]. With the 
further development of micro- and nanosensors, POC diagnostic devices will 
provide for improved medical management, leading eventually to self-regulated 
POC diagnostic devices that intermittently or continuously monitor the biological 
molecule of interest and deliver the therapeutic agents as required. 
Additionally, nanoscale science and engineering have accelerated the 
development of novel drug delivery systems and led to enhanced control over 
how a given pharmaceutical is administered, helping biological potential to be 
transformed into medical reality [79]. Micro- and nanoscale devices have been 
fabricated using integrated circuit processing techniques and have been 
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demonstrated to allow for strict control over the temporal release of the drug. 
Silicon microchips that can provide controlled release of single or multiple 
chemical substances on demand via electrochemical dissolution of the thin anode 
membranes covering microreservoirs have been created [80]. The advantages of 
this microdevice are that it has a simple release mechanism, very accurate 
dosing, and ability to have complex release patterns, potential for local delivery, 
and possible biological drug stability enhancement by storing in a microvolume 
that can be precisely controlled. More recently, multi-pulse drug delivery from a 
resorbable polymeric microchip device was demonstrated [81]. 
In particular, the development of polymer systems that are able to interact with 
their environment in an “intelligent” manner has led to novel materials and 
applications. These intelligent materials are attractive options as functional 
components in micro- and nanodevices, due to the ease with which their 
recognition and actuation properties can be precisely tailored. In addition to 
advances in polymer nanotechnology for sensing and recognizing changes in 
micro-environments, advances have been made concerning tissue regeneration 
on ceramic and metallic nanomaterials. 
Broadly speaking, nanotechnology embraces a system whose core of materials is 
in the range of nanometers (10−9 m) [82-92]. The application of nanomaterials for 
medical diagnosis, treatment of failing organ systems, or prevention and cure of 
human diseases can generally be referred to as nanomedicine [51,52]. The 
branch of nanomedicine devoted to the development of biodegradable or 
nonbiodegradable prostheses fall within the purview of nanobiomedical science 
and engineering [51,52]. Although various definitions are attached to the word 
“nanomaterial” by different experts, the commonly accepted concept refers 
nanomaterials as that material with the basic structural unit in the range 1 to 100 
nm (nanostructured), crystalline solids with grain sizes 1 to 100 nm 
(nanocrystals), individual layer or multilayer surface coatings in the range 1 to 
100 nm (nanocoatings), extremely fine powders with an average particle size in 
the range 1 to 100 nm (nanopowders) and, fibers with a diameter in the range 1 
to 100 nm (nanofibers) [42,43]. 
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Since nature itself exists in the nanometer regime, especially tissues in the 
human body [53], it is clear that nanotechnology can play an integral role in 
tissue regeneration. Specifically, bone is composed of numerous nanostructures 
— like collagen and hydroxyapatite (HA) that, most importantly, provide a unique 
nanostructure for protein and bone cell interactions in the body [50]. Although the 
ability to mimic constituent components of bone is novel in itself, there are 
additional reasons to consider nanomaterials for tissue regeneration such as in 
orthopedic applications: their special surface properties compared to 
conventional (or micron constituent component structured) materials [87-90]. For 
example, a nanomaterial has increased numbers of atoms at the surface, grain 
boundaries or material defects at the surface, surface area, and altered electron 
distributions compared to conventional materials [90].  
In summary, nanophase material surfaces are more reactive than their 
conventional counterparts. In this light, it is clear that proteins which influence cell 
interactions that lead to tissue regeneration will be quite different on nanophase 
compared with conventional implant surfaces. 
 
Despite this, the evolution of tissue engineering has centred on the use of 
materials with non-biologically inspired micron surface features [93, 94], mostly 
changing in chemistry or micron roughness but not degree of nanometer 
roughness. In this context, it should not be surprising why the optimal tissue 
engineering material (in particular, to regenerate bone) has not been found. 
4.2. Current research efforts to improve 
biomedical performance at the nanoscale. 
Nanoscale materials currently being investigated for bone tissue engineering 
applications can be placed in the following categories: ceramics, metals, 
polymers, and composites thereof. Each type of material has distinct properties 
that can be advantageous for specific bone regrowth applications. For example, 
HA, a ceramic mineral present in bone, can also be made synthetically. 
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Ceramics, though, are not mechanically tough enough to be used in bulk for 
large-scale bone fractures. However, they have found applications for a long time 
as bioactive coatings due to their ionic bonding mechanisms favourable for 
osteoblast (or bone-forming cells) function [95]. Unlike ceramic materials, metals 
are not found in the body. Due to their mechanical strength and relative inactivity 
with biological substances, metals (specifically, Ti, Ti6Al4V, and CoCrMo) have 
been the materials of choice for large bone fractures [93, 94]. Polymers exhibit 
unique properties (such as viscosity, malleability, moldability) and possess 
mechanical strength that is comparable with many soft (not hard) tissues in the 
body [96]. To date, because of their excellent friction properties, polymers (like 
ultra-high-molecular-weight polyethylene) have been primarily used as 
articulating components of orthopaedic joint replacements [97]. Additionally, 
some polymers (particularly the polyester family) can be reabsorbed or degraded 
in the body, which opens the window for controllable repair of damaged bone that 
is actively being investigated in tissue engineering circles. 
 
Lastly, composites of any or all of the above can be synthesized to provide a 
wide range of material properties to increase bone implant performance [59]; 
such ability to tailor composite properties to specific orthopaedic applications 
makes them attractive. 
Owing to the numerous materials currently being used and investigated in 
orthopaedics, select efforts to create nanoscale surfaces in all of these 
categories: ceramics, metals, polymers, and composites are reviewed. Several 
current and potential materials that have shown promise in nanotechnology for 
bone biomedical applications as well as needed future directions will be 
emphasized. 
4.3. Ceramic nanomaterials 
Perhaps slightly more mature, is the application of nanophase ceramics in bone 
tissue engineering applications. The next series of sections will highlight the 
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improvement in bone regeneration that can be obtained through the use of 
ceramic nanotechnology. 
 
4.3.1. Increased osteoblast functions 
The first report correlating increased bone cell function with decreased material 
grain or particulate size into the nanometer regime dates back to 1998 and 
involves ceramics [98]. Such reports described how in vitro osteoblast (bone-
forming cell) adhesion, proliferation, differentiation (as measured by intracellular 
and extracellular matrix protein synthesis such as alkaline phosphatase), and 
calcium deposition were enhanced on ceramics with particulate or grain sizes 
less than 100 nm [98-107]. 
Specifically, this was first demonstrated for a wide range of ceramic chemistries 
including titania, alumina, and HA [100]. For example, four, three, and two times 
the amount of calcium- mineral deposition was observed when osteoblasts were 
cultured for up to 28 days on nanophase compared with conventional alumina, 
titania, and HA, respectively [102]. It is important to note that for each respective 
nanophase and conventional ceramic mentioned in these first reports, similar 
chemistry and material phase were studied [98-107]. That is to say, only the 
degree of nanometer surface features were altered between respective 
nanophase and conventional alumina, titania, and HA. This is important since as 
previously discussed it is well known that alterations in surface chemistry will 
influence bone cell function [93-95, 97, 108, 109], but this was the first time 
changes in the degree of nanometer roughness alone were reported to enhance 
bone cell responses [98]. 
Although these studies provided preliminary evidence that osteoblast functions 
can be promoted on nanostructured materials compared with conventional 
materials regardless of ceramic chemistry, Elias et al. [110] further described a 
study where the topography of compacted carbon nanometer fibers were 
transferred to poly-lactic-glycolic acid (PLGA) using well-established silastic mold 
techniques. The same procedure was followed for compacts composed of 
conventional carbon fibers. The successful transfer of nanometer surface 
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features in compacted carbon nanometer fibers and micron surface features in 
conventional fiber compacts were compared. Importantly, osteoblast adhesion 
increased on PLGA molds made from nanometer fibers compared to 
conventional carbon fibers [110]. Increased osteoblast functions were also 
observed on the original nanometer fiber material compared with conventional 
carbon fiber compacts. In this manner, this study provided further evidence of the 
importance of nanometer surface features (and not chemistry) in promoting 
functions of bone-forming cells. 
Equally interesting, a step-function increase in osteoblast performance has been 
reported at distinct ceramic grain sizes, specifically at alumina and titania 
spherical grain sizes below 60 nm [100]. This is intriguing since when creating 
alumina or titania ceramics with average grain sizes below 60 nm, a drastic 
increase in osteoblast function was observed compared to respective ceramics 
with grain sizes just 10 nm higher (i.e., those with average grain sizes of 70 nm) 
[100]. This critical grain size for improving osteoblast function is also of 
paramount importance since numerous other special properties (such as 
mechanical, electrical, catalytic) of materials have been reported when grain size 
is specifically reduced to below 100 nm [[82-90]. With this information, evidence 
has been provided to show for the first time that the ability of nanophase 
ceramics to promote bone cell function is indeed limited to grain sizes (or 
subsequent surface features) below 100 nm, specifically below 60 nm [100]. 
Thus, another novel size-dependent property of nanostructured ceramics has 
been elucidated by these studies. 
Although an exact explanation as to why greater bone regeneration is observed 
on smaller grain size ceramics in the nanometer regime is not known to date, it is 
believed that the importance of this specific grain size in improving osteoblast 
function is connected with interactions of vitronectin (a protein known to mediate 
osteoblast adhesion with linear dimensions remarkably similar to the critical grain 
size of 60 nm mentioned above) [101, 106]. Moreover, as mentioned previously, 
several studies have indicated that vitronectin and other proteins important for 
osteoblast adhesion are more well spread and thus expose amino acid 
sequences to a greater extent when interacting with nanometer ceramics 
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compared with conventional ceramics [101, 106]. It is also intriguing to note that 
numerous investigators have confirmed that the minimum distance between 
protein ligands (such asarginine-glycine-aspartic acid or RGD) necessary for cell 
attachment and spreading is in the nanometer regime (specifically from 10 to 440 
nm depending on whether the study was completed with full proteins, protein 
fragments, or single RGD units) [111-116]. Therefore, an underlying substrate 
surface that mediates protein spreading (as opposed to protein folding) to expose 
such ligands, coupled with a nanometer surface roughness to further project such 
ligands to the cell, may promote cell adhesion due to this optimal ligand spacing. 
 
4.3.2. Increased osteoclast function 
In addition to studies highlighting enhanced osteoblast function on nanophase 
ceramics, increased functions of osteoclasts (bone-resorbing cells) have been 
reported on nanospherical compared with larger grain size alumina, titania, and 
HA [107]. Specifically, osteoclast synthesis of tartrate-resistant acid phosphatase 
(TRAP) and subsequent formation of resorption pits was up to two times greater 
on nanophase compared to conventional ceramics such as HA. Coordinated 
functions of osteoblasts and osteoclasts are imperative for the formation and 
maintenance of healthy new bone juxtaposed to an orthopaedic implant [54]. 
Frequently, newly formed bone juxtaposed to implants is not remodelled by 
osteoclasts and thus becomes unhealthy or necrotic [96]. At this time, the exact 
mechanism of greater functions of osteoclasts on nanophase ceramics is not 
known, but it may be tied to the well-documented increased solubility properties 
of nanophase compared with conventional materials [88]. In other words, due to 
larger numbers of grain boundaries at the surface of smaller grain size materials, 
increased diffusion of chemicals (such as TRAP) may be occurring to 
subsequently result in the formation of more resorption pits. 
Collectively, results of promoted functions of osteoblasts coupled with greater 
functions of osteoclasts imply increased formation and maintenance of healthy 
bone juxtaposed to an implant surface composed of nanophase ceramics. In fact, 
although not compared with conventional grain size apatite-coated metals, some 
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studies have indeed demonstrated increased new bone formation on metals 
coated with nanophase apatite [71]. Incidentally, coating metals with nanophase 
HA has been problematic [117]. For example, owing to their small grain size, 
techniques which use high temperatures (like plasma spray deposition) are not 
an option since they will result in HA grain growth into the micron regime [117]. 
To circumvent such difficulties, some investigators have allowed nanophase HA 
to precipitate on metal surfaces; this can be time consuming and not very 
controllable [71]. In contrast, others have developed novel techniques which use 
high pressure- based processes that do not significantly create elevated 
temperatures to coat nanophase ceramics on metals so as to retain their 
bioactive properties [118]. 
4.3.3. Decreased competitive cell functions 
Importantly, it has also been shown that competitive cells do not respond in the 
same manner to nanophase materials as osteoblasts and osteoclasts do [101, 
102, 119]. In fact, decreased functions of fibroblasts (cells that contribute to 
fibrous encapsulation and callus formation events that may lead to implant 
loosening and failure [108] and of endothelial cells [cells that line the vasculature 
of the body]) have been observed on nanophase compared with conventional 
ceramics [101]. In fact, the ratio of osteoblast to fibroblast adhesion increased 
from 1:1 on conventional alumina to 3:1 on nanophase alumina [94]. 
Previously, such selectivity in bone cell function on materials has only been 
observed through delicate surface chemistry (e.g., through the immobilization of 
peptide sequences like Lys-Arg-Ser-Arg or KRSR) [120]. It has been argued that 
immobilized delicate surface chemistries may be compromised once implanted 
due to macromolecular interactions that render such epitopes non-functional in 
vivo. For these reasons, it is important to note that studies demonstrating select 
enhanced osteoblast and osteoclast functions with decreased functions of 
competitive cells on nanophase materials have been conducted on surfaces that 
have not been chemically modified by the immobilization of proteins, amino acids, 
peptides, or other entities [101, 110, 119]. Rather it is the unmodified, raw 
material surface that is specifically promoting bone cell functions. 
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Fibroblast function was also investigated in the same study that was previously 
mentioned in which Elias et al. transferred the topography of compacted carbon 
nanometer fibers compared to conventional fibers to PLGA using well-established 
silastic mold techniques [111]. Similar to the observed greater osteoblast 
adhesion already noted, decreased fibroblast adhesion was measured on PLGA 
molds synthesized from carbon nanometer fibers compared to conventional fibers 
[111]. Again, this was the same trend observed on the starting material of carbon 
nanometer fiber compacts compared to conventional fiber compacts [111]. Thus, 
this study demonstrated the importance of a nanometer surface roughness (and 
not chemical composition of the material) in decreasing functions of fibroblasts 
that may lead to undesirable fibrous encapsulation and callus formation events 
inhibiting osseointegration of orthopedic implants with surrounding bone. 
 
4.3.4. Increased osteoblast functions on nanofibrous 
materials 
Recently, researchers have further modified nanophase ceramics to simulate not 
only the nanometer dimension but also the aspect ratio of proteins and HA 
crystals found in the extra-cellular matrix of bone [119]. For example, 
consolidated substrates formulated from nanofibrous alumina (diameter = 2 nm, 
length > 50 nm) increased osteoblast functions in comparison with similar 
alumina substrates formulated from the aforementioned nanospherical particles 
[119]. Specifically, Price et al. [119] determined a twofold increase in osteoblast 
cell adhesion density on nanofiber vs conventional nanospherical alumina 
substrates, following only a 2-h culture. Greater subsequent functions leading to 
new bone synthesis has also been reported on nanofibrous compared to nano- 
and conventional spherical alumina [119]. Thus, perhaps not only is the 
nanometer grain size of components of bone important to mimic in materials, but 
the aspect ratio may also be key to simulate in synthetic materials to optimize 
bone cell response. 
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Another class of novel biologically inspired nanofiber materials that have been 
investigated for orthopedic applications are self-assembled helical rosette 
nanotubes [121]. These organic compounds are composed of guanine and 
cytosine DNA pairs that self-assemble when added to water to form unique 
nanostructures. These nanotubes have been reported to be 1.1 nm wide and up 
to several millimeters wide [121]. Compared to currently used titanium, recent 
studies have indicated that osteoblast function is increased on titanium coated 
with helical rosette nanotubes [121]. Although in these studies it has not been 
possible to separate the influence of nanometer dimensions from the effects of 
nanotube chemistry on cell functions, it is clear that these nanotubes are another 
category of novel nanostructured materials that can be used to promote bone 
formation. It is also intriguing to consider what role self-assembled nanofibers 
may play in orthopedics since bone itself is a self-assembled collection of 
nanofibers. 
In this context it is important to mention that only nanophase materials can mimic 
the unique aspect ratio of HA and proteins found in the extracellular matrix of 
bone; it is not possible for micron-sized materials to simulate the unique 
nanometer constituent components of bone. As mentioned previously, results 
concerning the importance of nanofibrous materials in promoting functions of 
osteoblasts have been reported for carbon and polymer molds of carbon 
nanofibers [110]]. These findings consistently testify to the unprecedented ability 
to create nanomaterials to mimic the dimensions of components of physiological 
bone to promote new bone formation. 
4.4. Metal nanomaterials 
Although much work has been conducted on nanophase ceramics for orthopedic 
applications to date, several recent studies have focused on the analysis of bone 
regeneration on nanophase metals. Metals investigated to date include titanium, 
Ti6Al4V, and CoCrMo [122]. While many have attempted to create 
nanostructured surface features using chemical etchants (such as HNO3) on 
titanium, results concerning increased bone synthesis have been mixed [97]. 
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Moreover, through the use of chemical etchants it is unclear what the cells may 
be responding to — changes in chemistry or changes in topography. For this 
reason, as was done for the ceramics in this chapter, it is important to focus on 
studies that have attempted to minimize large differences in material chemistry 
and focus only on creating surfaces that alter in their degree of nanometer 
roughness. 
One such study by Ejiofor et al. [122] utilized traditional powder metallurgy 
techniques without the use of heat to avoid changes in chemistry to fabricate 
different particle size groups of Ti, Ti6Al4V, and CoCrMo. Increased osteoblast 
adhesion, proliferation, synthesis of extracellular matrix proteins (like alkaline 
phosphatase and collagen), and deposition of calcium containing mineral was 
observed on respective nanophase compared to conventional metals [122]. This 
was the first study to demonstrate that the novel enhancements in bone 
regeneration previously seen in ceramics by decreasing grain size can be 
achieved in metals. 
Interestingly, when Ejiofor et al. [122] examined spatial attachment of osteoblasts 
on the surfaces of nanophase metals, they observed directed osteoblast 
attachment at metal grain boundaries. Because of this, the authors speculated 
that the increased osteoblast adhesion may be due to more grain boundaries at 
the surface of nanophase compared to conventional metals. As was the case 
with nanophase ceramics [101, 106], it is plausible that protein adsorption and 
conformation at nanophase metal grain boundaries may be greatly altered 
compared to non-grain boundary areas and conventional grain boundaries; in this 
manner, protein interactions at grain boundaries may be key for osteoblast 
adhesion. 
4.5. Polymeric nanomaterials 
For ceramics and metals, most studies conducted to date have created desirable 
nanometer surface features by decreasing the size of constituent components of 
the material, e.g., a grain, particle, or fiber. However, due to the versatility of 
polymers, many additional techniques exist to create nanometer surface 
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roughness values. In addition, polymers contribute even further to rehabilitating 
damaged tissue by possibly providing a degradable scaffold that dissolves within 
a controllable time while the native tissue reforms. Techniques utilized to 
fabricate nanometer features on polymers include e-beam lithography, polymer 
de-mixing, chemical etching, cast-mold techniques, and the use of spin-casting 
[122-130]. For those that have been applied to bone regeneration, chemical 
etching followed by mold casting and polymer de-mixing techniques have 
received the most attention [123, 124]. 
For chemical etching techniques, polymers investigated to date include PLGA, 
PU, and polycaprolactone [124, 126-128]. The idea proposed by Kay et al. has 
been to treat acidic polymers with basic solutions (i.e., NaOH) and basic 
polymers with acidic solutions (i.e., HNO3) to create nanosurface features [116]. 
Kay et al. observed greater osteoblast adhesion on PLGA treated with increasing 
concentrations and exposure times of NaOH only on two-dimensional films. As 
expected, data were also provided indicating larger degrees of nanometer 
surface roughness with increased concentrations and exposure times of NaOH 
on PLGA. Park et al. [126] took this one step further and fabricated three-
dimensional tissue engineering scaffolds by NaOH treatment of PLGA. When 
comparing osteoblast functions on such scaffolds, even though similar porosity 
properties existed between nontreated and NaOH-treated PLGA (since similar 
amounts and sizes of NaCl crystals were used to create the pores through salt-
leaching techniques), greater numbers of osteoblasts were counted on and in 
NaOH-treated PLGA [126]. Unfortunately, due to these fabrication techniques, it 
is unclear whether the altered PLGA chemistry or nano-etched surface promoted 
osteoblast adhesion; however, in light of the previous studies mentioned in this 
chapter, the authors of Ref. [126] suggested that the nanometer surface 
roughness of the NaOH-treated PLGA played an important role [126]. 
Studies have also been conducted on cell responses to polymers with changes in 
nanometer surface roughness without changes in chemistry. Specifically, Li et al. 
utilized polymer de-mixing techniques to create well-controlled nanometer islands 
of polystyrene and polybromo-styrene [129]. Although osteoblast functions have 
not been tested on these constructs to date, fibroblast morphology was 
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significantly influenced by incremental nanometer changes in polymer island 
dimensions. Again, this study points to the unprecedented control that can be 
gained over cell functions by synthesizing materials with nanometer surface 
features. 
 
Although not related to orthopedic applications, vascular and bladder cell 
responses have also been promoted by altering the topography of polymeric 
materials in the nanometer regime [124, 126, 128, 130]. In these studies, 
chondrocytes [124], bladder [128], and vascular smooth muscle cell [127] 
adhesion and proliferation were greater on two-dimensional nanometer surfaces 
of biodegradable polymers such as PLGA, PU, and polycaprolactone; similar 
trends have recently been reported on three-dimensional PLGA scaffolds [130]. 
4.6. Composite nanomaterials 
Owing to the previous information of increased osteoblast function on ceramics 
[107] and polymers [119], bone cell function on nanophase ceramic polymer 
composites have also been determined. 
Specifically, studies conducted to date show promoted osteoblast responses on 
composites of PLGA combined separately with nanophase alumina, titania, and 
HA (30:70 wt% PLGA/ceramic) [131]. For example, up to three times more 
osteoblasts adhered to PLGA when it contained nanophase compared to 
conventional titania particles [124]. Since similar porosity (both percentages and 
diameters) existed between PLGA with conventional titania compared to 
nanophase titania, another novel property of nanophase ceramic composites was 
elucidated in this study: increased osteoblast functions. This is in addition to 
numerous reports in the literature highlighting greater toughness of nanophase 
compared to conventional ceramic/polymer composites [83, 85, 86]. 
Moreover, promoted responses of osteoblasts have also been reported when 
carbon nanofibers were incorporated into polymer composites; specifically, three 
times the number of osteoblasts adhered on PU with increasing weight 
percentages of nanometer carbon fibers when compared with conventional 
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dimension carbon fibres[132]. As mentioned, reports in the literature have 
demonstrated higher osteoblast adhesion on nanophase carbon fibers in 
comparison with conventional carbon fibers (or titanium [ASTM F-67, Grade 2] 
[132], but this study demonstrated greater osteoblast adhesion with only a 2 wt% 
increase of carbon nanofibers in the PU matrix. Up to three and four times the 
number of osteoblasts that adhered on the 100:0 PU/CN wt%, adhered on the 
90:10 and the 75:25 PU/CN wt% composites, respectively [132]. This exemplifies 
the unprecedented ability of nanophase materials to increase functions of bone 
cells whether used alone or in polymer composite form. 
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CHAPTER 
___________________________________ 
5 
5. Aims objectives and methods 
5.1. Rational of study 
To date, most tissue engineering studies are focused on the investigations of 
macro-level structures (e.g., supercellular structures >100 µm and cellular 
structures >10 µm) to build the essential gross morphology and generate real-
size organ systems. However, to ultimately engineer the functional units of the 
tissue, not only the supercellular and cellular scale structures but also the 
subcellular scale structures (0.1–10 µm) and nanostructures (1–100 nm) need to 
be constructed to control cellular environment, cell–molecular interactions, and 
cell–cell interactions. It is quite obvious that the full function of the tissues and 
organs cannot be recovered without rebuilding the ultrastructures of the tissue 
itself. The future of tissue engineering is highly dependent upon our profound 
knowledge of how subcellular and even smaller structures affect cell functions 
and how this knowledge will be transformed into technologies to fabricate 
biomimetic organ scale structures with subcellular resolution and nanoresolution, 
e.g., integration of functional cells into 3D architectures (scaffold) with nano-
resolution structures for improved tissue functionality. 
Therefore, engineering tissue toward the miniaturization at the nano-level is one 
of the most promising directions for tissue engineers. With the advent of 
nanotechnology, it is now possible to develop techniques to modify the surface 
structures and properties of biomaterials in order create the appropriate 
microenvironment for cells with predictable physical and biological properties.  
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5.2. Scope of Thesis  
The scope of this thesis was to identify problems in current applied tissue 
engineering research and hence formulate problem based solutions exploiting 
the emerging micro-nanoscale technology to contribute to the development of 
better natural and synthetic materials and innovative scaffolds. 
5.3. Aims of the study 
A) To develop an innovative scaffold that mimics native cellular micro-
environment, in order to guide and control cell viability and function, so that 
indefinite graft survival and clinically viable therapy can be achieved. 
B) To explore and develop a renewable source of tissue cells for use in tissue 
engineering. 
5.4. Objectives 
In particular;  
• To develop biomaterials with innovative surface geometry that promotes 
precise control of cell response at the graft-biomaterial and host-
biomaterial interface. 
• How to incorporate these surface geometries into supracellular 3D 
scaffolds, indispensable for tissue support and organization. 
• To optimise tissue perfusion in the 3D scaffold.  
• Recruitment of capillaries to penetrate the scaffold in order to maintain an 
oxygen gradient compatible with cell survival deep in the interior of the 
scaffold given that the graft is transplanted in ectopic sites, like 
subcutaneous or retroperitonium, without adequate vascularisation. 
• To overcome inevitable foreign body reaction whereby the host 
encapsulates foreign bodies with fibrotic sac hereby completely isolating 
the graft from nutrients. 
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• Transform the scaffold into an immuno-protective device through scaling 
down the heights of the fluidic channels. The resulting semipermeable 
membrane should block the passage to large sized components of the 
immune system but allow the passage to smaller sized nutrients and 
hormones 
• To develop innovative surface geometry that promote precise control of 
stem cell proliferation and differentiation so as to have a renewable 
source of pure harvests of differentiated cells. 
5.5. Methods  
In this section we describe 3 classes of experiments that were performed with the purpose 
of investigating independently each of the research objectives mentioned above. This was 
in the framework of the Master protocol for the development of medical devices outlined 
in Chapter 1, fig 1.2. 
5.5.1. Scaffold surface geometry design 
Using a combination of standard and “smart” microfabrication techniques a 
number of innovative surface geometry with 2 scale lengths (micro- and nano-) 
were formulated. A selection of natural and synthetic polymers were used. A total 
of 12 samples with different combinations of surface geometry and substrate 
material were developed. The resulting surface geometry was characterised by 
Scanning Electron Microscopy (SEM). Samples were tilted at 69 degrees to show 
the depth and features. 
5.5.2. Surface Design Optimisation. 
In order to investigate cellular response to the surface design, in vitro and in vivo 
studies were carried out using candidate substrates in parallel to the 
microfabrication of new ones with improved design. This as to ensure that there 
was a result-orientated feedback at every stage of the design and 
microfabrication process, so that surface geometry and biomaterials that 
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promoted favourable cell response (coined “smart”) were maintained and 
optimised and those with poor results were dropped. 
5.5.3. Cell Culture on Biomaterial. 
Candidate substrates for biological studies were microfabricated in such a way 
that half of the surface was covered with the “smart” surface geometry under 
investigation. The other non-patterned half (but of the same material)l acted as 
control. Neuroblastoma cells (mouse PC12 cell line), muscle myoblasts (mouse 
C2C12 cell line) and embryonic stem cells [ESCs (mouse non transformed TBV-2 
ES cell line)] were used for the study. 
Neuroblastoma cells were seeded on the substrates and cultured in growth 
medium composed of Foetal Bovine Sera (FBS) 10% and Roswell Park Memorial 
Institute media (RPMI) 90% for 5 days. The substrates received no cell adhesion 
protein treatment and no growth factors were added to the culture medium during 
the period of study. 
In order to get an expanded quantity of undifferentiated cells, ESCs were grown 
on murine embryonic fibroblast (MEF) feeder in ES medium (Knockout 
Dulbecco’s modified eagle medium supplemented with 15% FBS, 0.1 mM non-
essential amino acids, 50mM (2)b-mercaptoethanol, 2 mM L-alanyl-L-glutamine, 
100U/ml Penicillin, 100mg/ml Streptomycin and 1,400 U/ml of Leukemia inhibitory 
factor (ESGRO-LIF)which acted as the cell differentiation. Cell replating was 
done every three to four days.  
The expanded cells were then seeded on candidate substrates using the above 
culture medium but without Leukemia inhibitory factor (ESGRO-LIF). 
The specific culture protocol of muscle myoblasts is described elsewhere. All 
experiments reported above were performed in sterile conditions  and according 
to regulations laid down by the Experiments Committee of the University of Pavia 
and The International School of Advanced Studies (SISSA) Trieste. 
 
 
Myoblast cells response to the candidate biomaterials was evaluated using PCR 
assay for gene protein expression. Scanning Electron microscopy was used to 
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evaluate Neuroblastomas and Embryonic Stem Cell response. Parameters 
evaluated were cell adhesion to substrate, cell survival and proliferation, cell 
differentiation. 
Only the candidate biomaterials that passed this biocompatibility performance 
benchmark progressed to the next phase of research protocol: scaffold micro-
fabrication as was outlined in the Master Protocol in fig 1.2. 
5.5.4. Scaffold Design 
In order to address the problems of inadequate scaffold perfusion, fibrotic 
overgrowth, poor vascularization and immune rejection, we coined an original 
scaffold design with “smart” structural characteristics that would enhance scaffold 
perfusion and elicit desirable host response. A detailed description of the blue 
print and the rational of the design is presented in the discussion. 
5.5.5. Scaffold Microfabrication Protocol 
Described below is the microfabrication process based on the scaffold design we 
developed using the biomaterials and integrating the “smart” surface geometry 
that passed the performance benchmark using in vitro cell cultures. 
 
Step 1 etching of position markers 
A double-polished silicon wafer was used. 100nm of Cr was plated on the 
backside by metallic evaporation. This was followed by standard spin coating of 
positive resist (S1828) at 1500 rpm, soft baking (100°C for 3min), and 
photolithography using a photomask with alignment markers. This was followed 
by development of the resist and chromium wet etching in a solution of [35ml 
CH3COOH+ 600ml H2O +200g (NH4)2Ce(NO3)6] With chromium acting as the 
mask the markers were completely etched from back to front of the wafer using 
Inductively Coupled Plasma (ICP). Bosh® process was used. A schematic 
summary o this process is outlined in fig 5.1. 
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Fig 5.1 (a) through to (d) side view of a schematic representation of step 1 of the 
microfabrication process: etching of markers. 
 
Step 2  
On the frontside a base-plating layer Cr/A (Cr10nm Au 20nm) was deposited by 
metallic evaporation. This was to facilitate the subsequent electroplating. Positive 
resist PMMA (220K AR-649.04) was spin coated on the Cr/Au base-plating. At 
spin coating speeds up to 6000 rpm we were able to scale down the resist 
thickness to the order of ten nanometres. After soft backing at a temperature of 
175°C for 3 minutes, another layer of S1828 positive resist was spin coated at 
1500rpm followed by soft baking a temperature of100°C for 3 minutes. 
Photolithography was performed using a photomask with a grid pattern. After 
developing S1828, the grid pattern was then effectively transferred to PMMA 
resist by reactive ion etching (RIE) using oxygen plasma. S1828 was then 
stripped off by blank UV exposure and developed leaving a patterned PMMA 
layer. 
This pattern in the form of a grid network was to act as a spacer during the 
electrolytic growth of the gold hemi-membrane, and as a sacrificial layer whose 
chemical stripping at the end of the microfabrication process would result in a 
microfluidic network connecting the micropores of the gold and silicon hemi-
membrane. A schematic summary of this process is outlined in fig 5.2. 
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Fig 5.2 Side view of a schematic representation of step 2 of microfabrication 
process (A-F) for creating a grid network of a sacrificial layer in PMMA. 
 
 
Step 3. 
Positive resist (S1828) was spin coated and photolithography was done using the 
pore mask 1 after alignment with the markers on the silicon wafer. The resist was 
developed to leave behind an array of 100µm diameter pillars sitting on the 
PMMA grid thus forming the mould which was to act as a spacer for the 
nanopores during electrolytic gold plating [fig. 5.3 (a-b)]. 
 
Step 4 Gold Electroplating 
After plasma surface cleaning at low power (50W, 0.17W/cm2) for efficient 
electroplating, gold electroplating was carried out to obtain the complementary 
pattern of the array of pillars in S1828 to height of 2µm. (fig 6.3 c). The resulting 
structure was the gold hemi-membrane. 
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Fig. 5.3 Side-view of a schematic presentation step 3 of microfabrication process 
of the pillar patterned sacrificial layer that acts as a spacer for micropores during 
electrolytic gold plating. (c) Magnified insert of the resulting nanofluidic channels 
exhibiting nanometric and micrometric size in the vertical and lateral direction 
respectively. The nanometric control is obtained by the deposition of a sacrificial 
layer of precise nanometric thickness. 
 
 
 
Step 5 Micropore etching on the backside. 
Positive resist (S1828) was spin coated on the backside and then using the 
position markers, pore mask 2 was aligned to the silicon wafer and exposed. The 
resist was developed followed by chromium wet etching. 100µm diameter pores 
were then plasma etched with ICP in the silicon substrate until coming in contact 
with the Cr/Au base plating which acted as the etch stop. The base plating was 
then etched away using Cr and Au wet etching solutions respectively, to gain 
access to the PMMA grid below. The structure was then immersed in warm 
acetone that stripped the PMMA grid network and S1828 pillars spacers to create 
a semi-permeable microporous scaffold whose micropores were interconnected 
by a microfluidic network (fig. 5.4). 
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Fig. 5.4 (a) through to (g). Side-view of a Schematic presentation step 5 of 
microfabrication process: backside membrane pores created by ICP on silicon 
substrate. (g) Magnified insert of scaffold prototype .The stripping of spacer resist 
in warm acetone results in a network of nanofluidic cannals connecting the 
laterally displaced micropores to produce a semipermeable scaffold. 
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5.5.6. Host response to Biomaterial 
5.5.6.1. 
5.5.6.2. Matrigel® 
Controlled Host Response at Biomaterial/Scaffold-Host 
Interface using “smart” surface geometry 
Candidate gold and silicon microfabricated scaffold chips with “smart” surface 
geometry with micropores of varying diameters on one surface were evaluated 
using an animal model. 
The chips were surgically introduced into 4 subcutaneous pockets made in the 
mice abdomen. The upper right contained a silicon chip and the lower right 
pocket, a gold chip. The chips’ microporous surface was coated with a 
commercially available neoangiogenic proteinous gel matrix, Matrigel®. Gold and 
silicon chips in pockets on the left without matrigel® acted as controls. A total of 6 
mice were used. On day 5, 10 and 15, two mice were sacrificed and the chips 
harvested for histology analysis. A graphic representation of the surgical 
procedure is illustrated in figures 5.5 – 5.7. 
 
BD Matrigel™ Matrix is a solubulized basement membrane preparation extracted 
from EHS mouse sarcoma, a tumor rich in Extracellular Matric (ECM) proteins. Its 
major component is laminin, followed by collagen IV, heparan sulfate 
proteoglycans, and entactin. At room temperature, BD Matrigel™ Matrix 
polymerizes to produce biologically active matrix material resembling the 
mammalian cellular basement membrane. Cells behave as they do in vivo when 
they are cultured on BD Matrigel™ Matrix. It provides a physiologically relevant 
environment for studies of cell morphology, biochemical function, migration or 
invasion, and gene expression. 
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Fig. 5.5 Coating scaffold chips with matrigel® which was maintained in liquid form at 4oC. The chip 
on the left had micropores with100µm diameter while that on the right had pores with a diameter of 
1.25mm. Blue arrow indicates needle of insulin syringe 
 
 
Fig. 5.6 Surgical implantation of scaffold chip in a subcutaneous pocket of the mouse abdomen 
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Fig. 5.7 Postoperative image of mouse abdomen with complete wound healing by primary intention 
and visible subcutaneous scaffold (delineated by blue arrows) 
 
5.5.6.3. Controlled Host Response at Biomaterial/Scaffold-Host 
Interface using surface chemistry 
In a parallel study a suspension of latex microcapsules (Polysciences Inc.) in 
normal saline (0.9%) were used to investigate the hosts body reaction to a 
biomaterial with different surface chemistry. The following chemical functional 
groups were use;. 
Polybead Amino microspheres.  
1.00 μm diameter mono disperse latex particles (in 2.5% aqueous suspension) 
containing primary amine surface functional groups. 
Polybead Carboxy-sulphate microspheres. 
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1.00 μm diameter mono disperse surfactant free polystyrene particles with 
primary carboxyl-sulphate surface functional groups. 
Polybead Carboxyl microspheres. 
4.50 μm diameter mono disperse polystyrene particles containing surface 
carboxyl groups 
Polybead Hydroxylate microspheres 
3.00 μm diameter mono disperse polystyrene particles containing surface 
hydroxyl groups. 
Polybead Sulfate microspheres. 
2.00 μm diameter mono disperse polystyrene with surface sulfate groups. 
Polybead Poly(methyl methacrylate) or PMMA microspheres 
1-10 μm diameter particles with surface carboxylic acid groups. 
Alginate poly-L-lysine (200 μm diameter) capsules were used as controls. 
Male Lewis rats (Charles River, Italia), weighing 300-400g were used in this 
study. 
For each candidate material, a suspension of empty candidate capsules in 0.9% 
normal saline were implanted, via a midline incision, in the retroperitoneal space 
over the ileopsoas muscle (50μl) and renal subcapsular space (10μl). Two rats 
were used for each candidate material. Kidney and muscle containing all the 
capsules were explanted after 4 weeks for digital image histological analysis 
 
All surgical procedures reported above were performed under general 
anaesthesia with diethyl ether and in sterile conditions according to regulations 
laid down by the Animal Experiments Committee of the University of Pavia.  
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CHAPTER 
___________________________________ 
6 
6. Results 
6.1. Biomaterial surface geometry characterization  
Reported below are the surface geometry of the biomaterials that demonstrated 
amplified cellular response. Fig 6.1 (a) shows Pattern 1, a silicone substrate with 
irregularly-regular pattern of concave craters of diameters ranging from 1µm to 
50nm. While fig. 6.1(b) shows Pattern 2, irregularly-regular pattern of trenches 
(1µm width) whose surface is covered with nano-grain geometry (100nm-20nm in 
size) in a silicon substrate. Fig 6.1 (c) shows Pattern 3, an irregularly regular 
pattern of nano-rods of varying diameter (100nm-200nm) and varying heights 
(50nm –100nm) in silicon. Fig 6.1 (d) shows Pattern 4, a gold substrate with 
irregularly regular nano-grains ranging from 10nm 100nm in size. Fig 6.1(e) 
shows Pattern 5, finger-like polymer strands on a metallic base (chromium). They 
too had an irregularly-regular pattern and were 200nm diameter and 200nm in 
height 
In spite of the differences in surface geometry and the different biomaterials from  
which they were microfabricated, it was observed  that all candidate biomaterials 
that showed amplified cellular response were characterized by surface geometry  
with combined micro- and nano-scale lengths 
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Fig 6.1. (a)–(e) Scanning Electron Micrograph (SEM) of surface geometry with 2 combined scale 
lengths (nano-on-micro) that elicited favourable cellular response. (a) pattern 1 (b) Pattern 2, (c) 
pattern 3, (d) Pattern 4, (e) Pattern 5. 
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6.2. Cell response to biomaterial and surface 
geometry. 
6.2.1. Neuroblastoma cells (mouse PC12 cell line) 
After a 5 day cell culture period, cell survival was proliferation was observed on 
all biomaterials made from polymer (Photo resist S1828), silicon and gold. 
However the following patterns elicited additional striking cellular response; 
Neuroblastomas (PC12) seeded on pattern 1 (fig 6.1) described above showed 
firm adhesion and morphological change from the immature spherical shaped 
cells to differentiating cells with growth cones (fig. 6.2). A similar response was 
observed when PC 12 cells were seeded on Pattern 2 (fig 6.3). However, pattern 
5 promoted full differentiation into neuron cells with well developed axons with an 
interconnecting network of axons. (fig. 6.4) 
No change in morphology or differentiation was observed on the non-patterned 
half of the biomaterial and the plastic floor of the culture wells that acted as 
controls. In conventional culture studies, Neuroblastoma cells differentiate only 
when Nerve Growth Factor (NGF) is added to the culture medium.  
6.2.2. Embryonic Stem Cells (ECSs) [mouse TBV-2 cell line] 
ESCs were cultured on gold substrates with micro canals of varying widths but of 
the same height and nano-grain surface geometry Exponential cell proliferation 
with coalescing cell colonies was observed on both micro patterned (fig. 7.5) and 
non-patterned gold substrates and the plastic wall of the culture wells that acted 
as controls at the end of the 5 day culture period. However when the microcanals 
dimensions were reduced to 4µm wide, 8µm period and 1µm height cell survival 
and adhesion to substrate was still observed but exponential proliferation and 
coalescing of colonies was blocked (fig. 7.6). 
 
 75
76 Results 
 
 
 
 
 
 
 
 
 
a 
 
b 
 
Fig 6.2 Scanning Electron micrograph (SEM) of a microfabricated “smart” pattern 1 on silicon 
substrate (a). The substrate was seeded with neuroblastomas (PCR12) and cultured for 5 days in 
basic culture medium without Nerve Growth Factor. (B) shows cell survival, adhesion, growth cone 
spreading as indicated by morphological change indicated by red arrows (b). 
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Fig. 6.3 Scanning Electron micrograph (SEM) of a microfabricated “smart” pattern 2 on silicon 
substrate (a). The substrate was seeded with neuroblastomas (PCR 12) and cultured for 5 days in 
basic culture medium without Nerve Growth Factor. (b) shows cell survival, proliferation and 
adhesion indicated by red arrows. 
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Fig 6.4. Scanning Electron micrograph (SEM) of a microfabricated “smart” pattern 3 on silicon 
substrate (a). The substrate was seeded with neuroblastomas (PCR 12) and cultured for 5 days in 
basic culture medium without Nerve Growth Factor. (b) shows change in cell morphology and 
differentiation into neurons (red arrows) with axons (blue arrows). 
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a 
 
 
b 
Fig 6.5 Scanning Electron micrograph (SEM) of a gold microfabricated micro-pattern canals (20µ 
width, 40µ period) with “smart” nano-grain surface geometry. The substrate was seeded with 
Embryonic Stem Cells (ESCs) on fibroblast feeder cells in ES culture medium. B) Magnification 
shows exponential cell proliferation with coalescing of colonies which tend to flatten out and follow 
the direction of the canals. 
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a 
 
 
b 
Fig 6.6 Scanning Electron micrograph (SEM) of gold microfabricated micro-pattern canals (4µ 
width, 8µ period) with “smart” nano-grain geometry. The substrate was seeded with Embryonic 
Stem Cells (ESCs) on fibroblast feeder cells in ES culture medium for 5 days. (b) magnification 
shows cell survival but with step-function decrease of exponential proliferation. 
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6.2.3. Muscle myoblast cells (mouse C2C12 cell line) 
Gold and silicon substrates with different surface geometry were seeded with 
C2C12, an embryonic muscle cell line and cultured in basic culture medium 
without growth factors for 5 days. RNA polymerase Chain Reaction test was 
carried out to detect the presence of RNA for α- actin and MLC3F expression. α- 
Actin and MLC3F proteins are expressed during cell adhesion/proliferation and 
differentiation respectively. The PCR results charts are presented in fig 6.7 
below. Yellow boxes depict the results of gold substrates and the Red boxes 
silicon substrates. In fig 6.7(a) all substrates promoted cell proliferation and 
except gold substrates G and C (blue arrows). Substrate C pattern was 4µm wide 
canals with 8µm period while Substrate G was coated with matrigel® before 
being seeded with cells. While Figure 6.7(b) demonstrates that all silicone 
substrates promoted myoblast differentiation into myocytes (blue arrows). No cell 
differentiation was observed on gold substrates (yellow box). 
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a 
b 
Fig 6.7 RNA polymerase Chain Reaction charts showing presence RNA that 
expresses α- actin and MLC3F proteins. α- Actin and MLC3F proteins are 
secreted during cell proliferation and differentiation respectively. Yellow boxes 
depict the gold substrates and the Red boxes the silicon substrates.). (a) all 
substrates promoted cell proliferation and except gold substrates G and C (blue 
arrows). (b) demonstrates that all silicone substrates promoted myoblast 
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differentiation into myocytes (blue arrows). No cell differentiation was observed 
on gold substrates (yellow box). 
 
6.3. Host response to Biomaterial 
6.3.1.  Controlled Host Response at Biomaterial/Scaffold-
Host Interface using surface chemistry. 
 
Renal subcapsular implantation site 
After one month of implantation in the renal subcapsular space, the six types of 
microcapsules were explanted and investigated for fibrosis. Results of all six 
capsules are expressed graphically in fig. 6.8. 
Carboxylsulfate microbeads provoked the least 14.73% (SD 8.4)(Fig3a). Amino 
beads provoked the most fibrosis with 38.79% (SD 9.93). Alginate poly lysine 
capsules that acted as controls provoked 36.61% (SD 9.5) fibrosis.  
 
Retro-peritoneal iliopsoas implantation site 
As described above the six types of microcapsules were explanted from the 
ileopsoas muscle and analysed. Results of all six capsules are expressed 
graphically in fig. 6.9. Carboxylate microcapsules provoked the least fibrosis 
24.09.% (SD 16.0) while Amino microcapsules provoked the most 49.9% 
(SD12.2) Alginate poly lysine capsules that acted as controls provoked 38.72.% 
(SD 4.14). A Fig 6.10a–6.10d are selected histological samples demonstrating 
isolation of the micropheres by pericapsular fibrosis with no pericapsular 
neovascularization observed. 
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Fig 6.8 Renal Subcapsular fibrosis provoked by microcapsules 
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Fig 6.9 Fibosis at muscle implant site provoked by microcapsules 
 
 
 
Fig. 6.10a 
Histological section of renal subcapsular 
inoculation of “AMINO” microspheres 
demonstrating pericapsulare fibrosis 
(black arrows)(100X; 1200X , Masson 
stain). 
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Fig. 6.10b 
Histological section of renal subcapsular 
inoculation of “Alginate PLL” 
microsphere demonstrating pericapsulare 
fibrosis (red arrows)(100X; 450X , 
Masson stain). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.10c 
Sirius Red stained histological section of 
retroperitonela muscle inoculated with 
“Alginate PLL” microspheres 
demonstrating pericapsular fibrosis 
(arrows) (450X). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.10d 
Sirius Red stained histological section of 
retroperitonela muscle inoculated with 
“Amino” microspheres demonstrating 
pericapsular fibrosis (arrows) (1220X). 
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6.3.2. Controlled Host Response at Biomaterial/Scaffold-
Host Interface using “smart” surface geometry. 
 
Both Gold and Silicon hemi-membranes had their micropores filled with matrigel 
and were subcutaneously implanted in the abdominal wall of mice and explanted 
on day 5 for histological analysis. Fig 7.11(a) broken line depicts the space that 
was occupied by scaffold which was removed to facilitate histology (it couldn’t be 
cur through). Red arrows demonstrate mild acute inflammatory reaction at the 
matrigel® - host interface which the host recognized as self. And severe acute 
inflammatory reaction on the silicon backside–host interface without micropores 
and matrigel® that acted as control. 
 
 
a 
Matrigel®
Fig 6.11 (a) At day 5 of explant histology demonstrates mild acute inflammation at the host-
matrigel® interface (red arrows) and severe acute inflammatory reaction at the non-patterned host-
biomaterial interface that acted as control (white arrows). 
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Fig 6.12(a) At day 10 of explant, histology demonstrates infiltration of the matrigel® by chronic 
inflammatory cells and marked neoangiogenesis, red arrows.  
 
 
b
Fig 6.12(b) At day 10 of explant that acted as control (without matrigel®), histology demonstrates 
chronic inflammatory reaction at the host-biomaterial interface (red arrows) and neoangiogenesis, 
(blue arrows) 
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Fig 6.13(c). At day 14 of explant, histology demonstrates granulation tissue with fibroblast and 
connective tissue with a high vascular index . The numerous ed dots depicts immature blood 
capillaries containing red blood cells (red arrows). 
 
 
 
6.4. Scaffold prototype 
The resulting scaffold was a microporous silicon scaffold assembled on a 
microporous gold semi-permeable membrane. The semi-permeability was 
guaranteed by nanofluidic network embedded between the gold and scoffold 
structure. The figures below are Scanning Electron Microscopy (SEM) 
characterisation of the device highlighting its macro- micro- and nano- 
architecture 
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6.14 Scanning Electron micrograph of top view 2 scaffold prototypes demonstrating its external gold 
hemi-membrane’s 3D architecture, microporosity and the integration of “smart” surface geometries 
that promoted desirable cellular response. Inserts; magnified and tilted micrographs (69o) 
demonstrating 3D architectures and microfluidic canals 
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2 
Fig. 6.15. Red arrows demonstrate the mouths of the microfluidic canals that interconnect the 
laterally displaced micropores of the gold membrane and the silicon scaffold. 
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Fig 6.16 Scanning Electron micrograph of a broken gold hemi-membrane of the scaffold prototype 
(1) to reveal the trajectory of microfluidic canals that connect micropores ( Red arrows). The sample 
is tilted at 69 degrees to show the depth of the islands (720nm) and channel features. Fig b. 
demonstrates the micro-nanoscale patterning 1 incorporated onto the scaffold surface. 
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Fig 6.17 Scanning Electron micrograph of the gold hemi-membrane of the scaffold prototype (2) 
demonstrating  micro-nanoscale patterning 2 incorporated onto the scaffold surface. 
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b 
6.18 (a) Scanning Electron micrograph of the backside of scaffold prototypes demonstrating its 
internal silicon hemi-membrane’s 3D architecture and microporosity (a) . Fig. (b). demonstrates the 
micro- nano-scale patterning 1 and 2 incorporated into the silicon micropore walls. 
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CHAPTER 
___________________________________ 
7 
7. Discussion 
In this chapter the concept and design of the scaffold are discussed. The scientific 
considerations that inspired the design and factors that influenced the construction of the 
prototype are outlined. The results and implications of the proof-of-concept biological 
investigations that were carried out are evaluated and future areas of study and potential 
applications are proposed. 
 
Cell survival, differentiation and function is regulated by precise biochemical, 
biophysical and neural signals. Further more, physiological function of cells is 
achieved and maintained through an architectural hierarchy of supporting 
structures and complementary cells that together form tissue. (as was outlined in 
chapter 2). In order to have any success in artificial engineering of tissue, these 
fundamental principles must be respected. 
 
This was against this background that we set out to design a scaffold that 
reflected these fundamental principals and for inspiration we looked at the 
structure of nature’s solution to tissue building: the extra-cellular matrix. 
The final design of our scaffold was a compromise between the incorporation of 
biological requisites for cell survival and function on one hand and technical -
logistical considerations on the other hand namely: choice of biomaterial, 
integration of surface geometry that gave the most desirable cellular response, 
engineering feasibility and structural integrity, production costs, access to 
technology  and the capacity to mass produce. 
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7.1. Scaffold Design and Architectural Hierarchy 
7.1.1. The Superstructure: The overall shape of the scaffold 
 
The scaffold consists of a square chip with the following dimensions 1cm (L) x 
1cm (W) x 350µm (H). It is composed of a 3 layers; a middle layer of microfluidic 
network embedded between two microporous membranes made of gold and 
silicon respectively. This miniaturized size of the scaffold have obvious 
advantages. It results in a reduced diffusion distance to the core of the scaffold 
and the large surface to volume ratio favours increased mass flow of nutrients 
and by products.  
Small chips minimize surgical trauma at the implantation site and hence promote 
healing by primary intention which is associated with minimal fibrotic overgrowth 
at the host-biomaterial interface (refer to fig 6.6). 
7.1.2. At the Micro-Scale: 
The two hemi membranes consist of a “smart” pattern of honeycomb-inspired 
micropores that confers them 3D architecture and porosity. The role 3D 
architecture in the promotion of tissue organisation, and cell function is well 
established. While porosity optimises perfusion and mass flow of biological fluids 
to the core of the scaffold. The choice of this design was further based on striking 
in vivo results where the micropous surface elicited vascular recruitment at the 
scaffold-host interface irrespective of the biomaterial used [fig 6.12(a)–6.12(b)]. 
This host response was further optimised by filling the micropoes with matrigel. 
On The other hand encapsulating fibrotic overgrowth was elicited in the controls 
and in a parallel study using latex with different surface chemistry (Fig 6.8-6.10). 
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7.1.3. The hydraulic aspect as of design  
 
The hemi-membranes are superimposed and aligned in such a way that the 
micropores are laterally offset (fig. 7.1). Sandwiched between these hemi-
membranes is a microfluidic canal network that runs perpendicular to the 
micropore axis and permits interconnectivity between the laterally offset 
micropores (fig 7.2.) The canals section is rectangular, with a width in the order of 
4 microns (limited by the resolution of the UV lithography), period of 8µm, and 
height which can scaled down to the range of 10nm, (corresponding to the 
thickness of a sacrificial layer) (7.3). 
 
Fig 7.1. Schematic representation of micropores of two superimposed hemi-membranes (A) and 
when laterally offset (B). 
  
Fig 7.2. Schematic representation of a microfluidic canal network embedded between two hemi 
membranes and interconnecting laterally displaced micropores. 
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a 
b 
Fig 7.3 CAD microfluidic canal network indicating parameters (b) inspired from blood capillary bed 
indicated in (a) 
 
The fluidic network design was inspired from the blood capillary network (fig.7.3a) 
and serves as nutrient channels to support cell survival deep in the interior of the 
scaffolds. 
By scaling down the height of the canals from the micro- to the nano-scale the 
scaffold acquires a “smart” characteristic as a semipermeable membrane and by 
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size exclusion can block the passage of large immune cells but permit the 
passage of nutrients and hormones. 
 
The external hemi-membrane serves as a scaffold for vascular endothelial cells 
and neoangiogenic stimulating matrix and is made of gold (fig.7.1). Gold was the 
biomaterial of choice because it was demonstrated to be non toxic in our cell 
culture studies and above all maintained structural and physical stability in 
biological solutions and at implantation site over a long period of time. The pore 
size diameter of 100µm was observed as the minimum diameter that was 
associated with adequate blood capillary penetration of the scaffold 
 
The internal hemi-membrane serving as a scaffold for the tissue of 
transplantation interest was made of silicon (fig. 7.2) The choice of silicon as a 
the scaffold for graft cells was based on combined ease of microfabrication of 
microscale geometry and the integration of nanoscale geometry that promoted 
desired cell response. The Micropores are 100µm in diameter with a period of 
220µm resulting in a pore density of 2066/cm2 This pore density was a 
compromise between structural integrity and the need to ensure mass flow of 
solutes across the membrane. We observed that high pore density resulted in 
brittle, easily breakable and disintegration on long term implantation. 
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Fig. 7.4 Functional unit of Computer Aided Design (CAD) of the outer microporous membrane 
inspired from the honeycomb (green circles). The dotted circles corresponds to the laterally offset 
position of the micropores the overlying inner membrane 
 
Fig. 7.5 Functional unit of Computer Aided Design (CAD) of the inner microporous membrane 
inspired from the honeycomb as well (green circles). The dotted circles correspond to the laterally 
offset position of the micropores of the underlying outer membrane as illustrated above in fig.1 
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Fig 7.6 3D schematic representation of the interconnectivity of two laterally offset porous hemi-
membranes by microfluidic canal sandwiched between them. 
 
7.1.4. At the Nano-Scale 
Biomaterial surface geometry and proof of concept 
Identification of biomaterials that support desirable cell responses such as 
cellular attachment, survival, proliferation and differentiation is critical for tissue 
engineering and cell therapy. The observation of how C2C12 myoblasts and PC 
12 neuroblastomas cultured on our “smart” biomaterials differentiated into 
myocytes and neurons respectively without the addition of growth factors into the 
culture medium is a striking demonstration that in vitro soft tissue cell 
differentiation can be precisely controlled using surface geometry. It was further 
observed that cell differentiation occurred only on substrates structured at two 
scale lengths (illustrated in fig 6.1) i.e. structures at the tens to hundreds microns 
as supporting scaffold and at the submicron scale for surface geometry. This 
didn’t happen when the same substrate was used but with regular patterns like 
pillar or canal arrays at the micron scale length (refer to results; section 6.2.3). 
Webster et al and other investigators (refer to chapter 4) have reported how vitro 
osteoblast adhesion, proliferation, differentiation (as measured by intracellular 
and extracellular protein synthesis as alkaline phosphates), and calcium were 
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enhanced on biomaterials with particulate or gain sizes less than 100nm. We can 
deduce that it is this hierarchal geometry that adds precision as a biophysical 
signal for cell differentiation To the best of our knowledge no one had until now 
reported inducing precisely controlled morphological differentiation using a 
biophysical signal.  
 
Equally interestingly we exploited this difference in cell response to surface 
geometry in our investigations on Embryonic Stem Cells (ESCs) as a renewable 
source of cells for tissue engineering. 
One of the major draw backs of ESCs as a renewable source of cells for tissue 
engineering is the inability to have precise control of their proliferation and failure 
to control their differentiation into pure cultures of target tissue cells. The step-
function decrease in ESCs exponential proliferation by narrowing the period 
between the micro patterns demonstrates that we can control ESCs proliferation 
using surface geometry. Although our preliminary findings are exciting, 
proliferation control must be coupled with precise differentiation control if the use 
of ESCs in tissue engineering is to have clinical relevance. Our research group is 
currently researching on innovative ways of optimising ESCs differentiation and 
function. 
7.2. Bioactively controlled host response 
(wound healing) at the host scaffold interface 
 
 
By combining microporous surface (that inhibits excessive fibrotic over growth), 
nanopatterned surface (that promotes protein adsorption and hence vascular 
endothelial cells attachment) and the filling of the micropores with vascular 
recruiting gel, matrigel®, we actively elicited the desired host response: vascular 
recruitment and penetration at the scaffold host interface. The clinical implication 
of this is two fold:  
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1) optimised ectopic graft function  
In their native environment functional/endocrine cells like hepatic and pancreatic 
islets cells has a very rich vascular supply in order to carry out their high oxygen-
consuming functions. When transplanted they are usually returned to low oxygen 
ectopic sites (refer to fig. 5.6) where even if they may survive they wouldn’t be 
able to carry out their endocrine function.  
2) Host-scaffold integration 
Orthopaedic and dental implants are associated with alarming failure rates. In the 
In the USA, 12.8% of the total hip arthoplasties in 1997 were simply due to 
revision surgeries of previously implanted failed hip replacements. While recent 
studies have found that dental implants which have been used in over 300,000 
cases have a success rate of 75% after 15 years. Although there are many 
reasons why implants fail, a central one is the lack of sufficient bone regeneration 
around the implant immediately after insertion. Shockingly, about one quarter of 
dental implant failures (those that fail between 3 and 6 months) are attributed to 
incomplete healing of the implant to juxtaposed bone. Therefore by designing 
surface characteristics that interface optimally with select proteins and 
subsequently with pertinent bone types, improved biomaterial performance can 
be achieved. 
7.3. Microfabrication Protocol 
Our microfabrication protocol was kept as simple was possible despite the fact 
that there are more elegant and refined protocols that could be formulated using 
state of the art technology like electron beam and x-ray lithography. But this had 
to be reconciled with logistical considerations such as mass production, 
technology transfer, and Industrial Investment given that industry is not willing to 
invest in high production cost using very expensive machines at that need highly 
specialized manpower. 
 
 
Discussion 103
 
7.4. Conclusion 
By developing the ability to control microporous architecture, micro pore 
interconnectivity and size, the external and internal shape of the scaffold and it’s 
nanometer scaled surface architectures, the  “smart” scaffold developed in our 
laboratories have great potential as an ideal scaffold for tissue engineering. 
7.5. Applications  
1. Micro 3D cell culture wells  
One of the immediate spin-off applications of our research is the integration of 
our innovative surface geometry into cell culture dishes to produce functional 
micro 3D cell wells. By combining traditional cell culture techniques and surface 
geometry we can create an in vitro micro environment that simulates the natural 
microenvironment of cells resulting in more physiologically accurate results.  
Further more, it would be cost effective since the miniaturized sizes and “smart” 
surface geometry results in the use of less consumables (cells, biological 
reagents) and time consuming complex culture protocols. Fig 7.7 illustrates a 
prototype of micro 3D cell culture wells for Pancreatic islets of Langerhans. 
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Fig 7.7 illustrates a micro 3D cell culture wells for Pancreatic islets of Langerhans 
7.6. Future areas of research 
1. Given the good results in toxicology, cytocompatibilty and biocompatibily by 
the “smart” biomaterials and scaffolds developed from them. We will pass on to 
the next phase of the study: tissue engineering and transplantation using animal 
models. The areas of research to be addressed are as follows: 
• Metabolic diseases; diabetes: Pancreatic islet of Langerhans  
regeneration 
• Spinal Cord injuries: neurons regeneration 
• Orthopaedic and Dental injuries: bone regeneration 
• Connective tissue diseases (Rheumatoid arthritis): Cartilage regeneration 
 
2. Integration of scaffold’s microfluidic network with external pump to create 
bioreactor to stem cell derived tissue research. 
3: Immuno-isolation studies 
We developed the technological capacity to make nanofluidic canals of down to 
10 nm height and hence transform the scaffold into an immuno isolating 
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membrane by size exclusion of antibodies. However, further studies are needed 
in this direction to reconcile the conflicting interest of graft revascularisation and 
immune protection. This has important therapeutic implications given that one of 
the biggest drawbacks to graft transplant is the need of chronic 
immunosuppression therapy that is associated with grave side effects. 
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